RNA-Protein Interactions in the U12-Dependent Spliceosome by Singh, Jagjit
Cleveland State University
EngagedScholarship@CSU
ETD Archive
2016
RNA-Protein Interactions in the U12-Dependent
Spliceosome
Jagjit Singh
Follow this and additional works at: https://engagedscholarship.csuohio.edu/etdarchive
Part of the Biology Commons
How does access to this work benefit you? Let us know!
This Thesis is brought to you for free and open access by EngagedScholarship@CSU. It has been accepted for inclusion in ETD Archive by an
authorized administrator of EngagedScholarship@CSU. For more information, please contact library.es@csuohio.edu.
Recommended Citation
Singh, Jagjit, "RNA-Protein Interactions in the U12-Dependent Spliceosome" (2016). ETD Archive. 946.
https://engagedscholarship.csuohio.edu/etdarchive/946
	RNA-PROTEIN INTERACTIONS IN THE U12-DEPENDENT 
SPLICEOSOME 
 
 
 
 
JAGJIT SINGH 
 
 
 
 
Bachelor of Science 
Panjab University 
May 2003 
 
 
 
Master of Science 
Punjab Agricultural University 
May 2006 
 
 
 
 
 
submitted in partial fulfillment of requirements for the degree of 
 
DOCTOR OF PHILOSOPHY IN REGULATORY BIOLOGY 
 
at the 
 
   
CLEVELAND STATE UNIVERSITY 
 
 
December 2016 
 
 
 
	 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Jagjit Singh 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	We hereby approve this dissertation for 
 Jagjit Singh  
Candidate for the Doctor of Philosophy in Regulatory Biology degree for 
the 
Department of Biological, Geological and Environmental Sciences and 
CLEVELAND STATE UNIVERSITY’S College of Graduate Studies by 
 
 
    Dr. Girish C. Shukla 
 
Dissertation Chairperson and Major Advisor 
 GRHD/BGES, Cleveland State University                                  Date: 12/12/2016 
 
 Dr. Barsanjit Mazumder 
 
Dissertation Committee Member  
GRHD/BGES, Cleveland State University                                  Date: 12/12/2016  
 
     Dr. Sailen Barik 
 
Dissertation Committee Member  
GRHD/BGES, Cleveland State University                                  Date: 12/12/2016 
 
 Dr. Aaron F. Severson 
 
Dissertation Committee Member  
GRHD/BGES, Cleveland State University                                   Date: 12/12/2016 
 
 Dr. Sadashiva Karnik 
 
Dissertation Committee Member  
Dept. of Molecular Cardiology, LRI                                        Date: 12/12/2016 
 
 Dr. Anton A. Komar 
 
Internal Examiner  
GRHD/BGES, Cleveland State University                                   Date: 12/12/2016 
 
 Dr. Richard A. Padgett 
 
External Examiner  
Dept. of Cellular and Molecular Medicine, LRI                             Date: 12/12/2016 
 
 
Student’s Date of Defense:  December 12, 2016    
	Dedication 
 
 
 
 
 
 
 
Dedicated to Almighty, 
 
My Family 
 
& 
 
My Friends 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	Acknowledgement 
 
First and foremost, I would like to thank my advisor Dr. Girish C. Shukla who 
has been the guiding force during this work. This day would not have been possible 
without him. He has been a great mentor and has taught me everything about 
science, from day-to-day running of experiments to how to think about my own 
work, and biology in general, in a larger context. His friendly and understanding 
nature has made working with him very enjoyable. Not only scientific discussions, 
his door was always open for healthy discussions, even if it is related to something 
personal. Words are not enough to express my gratitude for his patience and 
endless support towards me.   
  I would also like to thank the Advisory Committee Members, Dr. Mazumder, 
Dr. Barik, Dr. Severson and Dr. Karnik. All of them really appreciated the quality of 
my work and inspired me to work harder. They provided me with their valuable 
feedbacks during the course of my Ph.D. research.  
I am very thankful to Dr. Padgett (external reviewer) and Dr. Komar (internal 
reviewer) for agreeing to serve in my Ph.D. dissertation defense committee. Thank 
you Dr. Komar for your wonderful piece of advice in my protein related work and 
travel awards for attending the scientific meetings without any hesitations.  
The members of the Shukla lab, both former (Kavleen, Jinani, Tupa, Kevin 
& Neha) and current (Savita, Alexis, Narmada, Asmita & Maitri), have been great 
colleagues and have provided many valuable inputs into the work. At the same 
time, they have been very good friends and working with them has been a pleasure 
	and full of fun. I owe my sincere thanks to Jey Sabith, from the bottom of my heart, 
for supporting me out of the way in every aspect during this journey of Ph.D. 
I would like to thank all the administrative personnel especially Monica, Lisa 
and Carolee for their all-time help with any kind of official work. Also, the friends 
around the hallway are thanked for their support. 
I would like to acknowledge the Cellular and Molecular Medicine 
Specialization program for two years funding support towards this work and 
Cleveland State University for providing the Doctoral Dissertation Research 
Expense Award Fellowship to finish my doctoral studies.  
I am really blessed to have my older sister and brother-in-law. Thank you 
for always being there around the corner through my ups and downs in life. There 
can be no other older sister who worries about her little brother as she does for 
me. My nephew and my niece are my stress busters.  
 Last but not the least, my parents are the continuous source of inspiration 
that helped me chase my dream to complete my Ph.D. studies thousands of miles 
away from home which otherwise would have been remained only as a dream.  
  All the names might not have been included but none is forgotten. 
 
 
 
 
 
 
 
 
 
	This work is partially reprinted from 
 
Jagjit Singh, Kavleen Sikand, Heike Conrad, Cindy L. Will, Anton A. Komar 
and Girish C. Shukla.  
 
U6atac snRNA stem-loop interacts with U12 p65 RNA binding protein and is 
functionally interchangeable with the U12 apical stem-loop III. Scientific Reports. 
2016; 6: Article number: 31393. Doi:10.1038/srep31393  
viii	
	 	
RNA-PROTEIN INTERACTIONS IN THE U12-DEPENDENT 
SPLICEOSOME 
JAGJIT SINGH 
ABSTRACT 
 
Nuclear precursor messenger RNA (Pre-mRNA) splicing is an important 
regulatory step in metazoan gene expression. More than 99% of nuclear pre-
mRNA introns are U2-type that are spliced by U2-dependent spliceosome 
containing U1, U2, U4, U5 and U6 snRNAs. Only less than 1% of the introns are 
U12-type and spliced by U11, U12, U4atac, U5 and U6atac snRNAs. U12 and 
U6atac snRNAs play a central role in the splicing of U12-dependent introns. Our 
previous work demonstrated that the conserved 3′ stem-loop region of U6atac 
snRNA contains a U12-dependent spliceosome-specific targeting activity, 
however any potential molecular mechanism was unclear. We discovered that the 
distal 3′ stem-loop of U6atac has structural and sequence similarities with stem-
loop III of U12 snRNA. These observations convinced us to investigate the 
structure-function requirement of the substructure of the U6atac 3′ stem-loop in 
U12-dependent in vivo splicing. Our results show that the C-terminal RNA 
recognition motif of p65, a U12 snRNA binding protein, also binds to the distal 3′ 
stem-loop of U6atac. Using in vivo genetic suppressor assay, we demonstrate that 
stem-loop III of U12 snRNA which binds to p65 protein can be functionally replaced 
by U6atac distal stem-loop and vice-versa. Furthermore, we tested the 
compatibility of the U6atac 3' end from phylogenetically distant species in a human 
U6atac suppressor background to establish the evolutionary relatedness of these 
ix	
	 	
structures and in vivo functionality. In conclusion, we demonstrate that p65 C-
terminal RNA recognition motif interacts with the U6atac distal 3′ stem-loop. 
Although the significance of p65 binding to U6atac snRNA is not clear, our study 
suggests that both the helix structure, as well as the sequence of U6atac distal 3′ 
stem-loop is important for snRNA-protein interactions and U12-dependent intron 
splicing.  
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1      Splicing and its role in gene regulation 
 
  The comprehensive advancements in the transcriptomic studies revealed 
that 98% of a human genome is transcriptionally active and producing both the 
protein coding as well as the non-protein coding transcripts. In human genome, 
from the total of 26, 564 annotated genes are considered to contain approximately 
233,785 exons and 207,344 introns. Almost all the eukaryotic genes are initially 
transcribed into precursor mRNAs (pre-mRNAs) which are interrupted with at least 
one intron. On an average, there are 8.8 exons and 7.8 introns per gene 
(Sakharkar M.K. et al., 2004). Since only a mature mRNA can escape the nuclear 
surveillance and degradation mechanism, these introns have to be removed, in 
order to make the genetic message continuous. Therefore, in order to make 
mature mRNA that could actively engage to the translational process, all pre-
mRNAs must undergo different modifications such as modifications at the 5' end, 
3' end, and the removal of introns. In eukaryotes, the 5' and 3' end of the primary 
transcript are protected against the exonucleases with the help of the 5' 7mG cap 
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(Gao M., 2000) and the 3' polyadenylation tail respectively (Guhaniyogi J. and 
Brewer G., 2001). All three of the modifications mentioned above play an important 
role in gene regulation by different possible mechanisms, such as nuclear export, 
degradation, and translational enhancement (Visa N., 1996; Gao M., 2000; Meijer 
H. A., 2007; Sonenberg N. and Gingras A.C. 1998; Guhaniyogi J. and Brewer G., 
2001; Braddock M. et al., 1994; Matsumoto K. et al., 1998). Surprisingly, it was 
discovered that the introns and their act of removal, influences various other stages 
involved in RNA metabolism. These stages include the transcription of the gene, 
pre-mRNA editing and polyadenylation, nuclear export, translation, and mRNA 
decay. Hence, the process of intron removal contributes to significant differential 
expression profiles for the intron-containing and intron-less version of the same 
gene (Buchman A.R. and Berg P., 1988; Callis J. et al., 1987; Duncker B.P. et al., 
1997).   
   In Drosophila and humans, the electron micrograph analysis of actively 
transcribing genes depicts that pre-mRNA splicing occurs with fairly high frequency 
on the nascent transcripts. This analysis also supports the notion that the splice 
site recognition event generally precedes the polyadenylation. This existing 
evidence indicates that the splicing event occurs co-transcriptionally.  (Beyer A.L. 
and Osheim Y.N., 1988; Bauren G. and Wieslander L., 1994; Kiseleva E. et al., 
1994; Zhang G. et al., 1994; Pandya-Jones A. and Black D.L., 2009; de la Mata 
M. et al., 2010).  
  Introns could be either spliced by a constitutive splicing mechanism where 
all the exon in a gene at the 5' end of the intron are ligated to the exon at the 3’ 
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end of the intron. No exon skipping event takes place in the constitutive splicing 
mechanism. However, another mechanism with which an intron splices is the 
alternative splicing. Alternative splicing process involves the joining of different 5′ 
and 3′ splice sites, producing different spliced variants of the same gene. The 
proteins that are encoded by multiple mRNAs spliced variants, perform various 
diverse and sometimes even antagonistic functions.  Up to 59% of the total human 
genes undergo alternative splicing and generate multiple mRNAs (Lander E. S. et 
al., 2001), and approximately 80% of alternatively spliced variants alters the 
encoded protein (Modrek B. and Lee C., 2002). The variability in mRNA, due to 
alternative splicing, results in the a) introduction of a termination codon in the 
mRNA b) insertion or removal amino acids or c) frame shift of the reading frame in 
the expressed protein. The removal or insertion of important regulatory elements 
by the alternative splicing further affects the gene expression by controlling 
translation, mRNA stability, or localization is regulated. Alternative splicing alters 
the coding capacity of genomes by bringing huge diversity to the proteome 
capacity of a given cell (Sultan M. et al., 2008; Wang E.T. et al., 2008), and thereby 
playing a very significant role in regulating the gene expression (Blencowe B.J., 
2006). 
Nuclear pre-mRNA splicing is a two-step process involving two 
transesterification reactions catalyzed by a dynamic, multi-megaDalton 
ribonucleoprotein (RNP) machinery known as spliceosome (Will C.L. and 
Luhrmann R., 2005). In almost all metazoans, two types of introns have been 
identified so far. These are U2-dependent (major class) introns comprising more 
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than 99% and U12-dependent (minor class) introns comprising less than 1% of the 
total introns. These two types of introns differ in their consensus signature 
sequences and require different splicing machineries with almost similar splicing 
mechanisms. For the splicing of two different types of introns, two specific 
spliceosomes with unique components have been characterized. The U2-
dependent spliceosome, contains U2-type snRNAs and catalyzes the removal of 
U2-dependent introns (Moore M.J. et al., 1993; Burge C.B. et al., 1999) whereas, 
the rare class U12-dependent pre-mRNA introns are spliced by the U12-
dependent spliceosome and contain U12-dependent snRNAs (Tarn W.Y. and 
Steitz J.A., 1997; Burge C.B. et al., 1999; Wu Q. and Krainer A.R., 1999; Patel 
A.A. and Steitz J.A., 2003).  
It has been suggested that both U2 and U12 type introns co-evolved during 
the course of evolution, but U12-dependent introns were found to be missing in a 
number of organisms, such as budding yeast and nematodes. The U2-dependent 
introns as well as U2-dependent spliceosome are ubiquitously present in all 
eukaryotes whereas, the U12-dependent introns and their respective machinery is 
only present in a subset of eukaryotes (Burge C.B. et al., 1998). Both the U2- and 
U12-dependent spliceosomes coexist in eukaryotic cells, and the pre-mRNAs 
transcripts containing both types of introns serve as substrates for both the 
spliceosomes. 
Primarily, the spliceosome helps in the recognition of the intron/exon 
boundaries and the catalysis of the reaction that removes the intron and joining of 
the exons.  Spliceosomes are assembled on the pre-mRNA intron in a multistep 
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process during which the snRNPs, including five small non-protein coding nuclear 
RNAs, recognize and interact with the target intron cis-acting elements with the 
help of RNA-RNA base pair interactions. These events are also facilitated by 
additional splicing factors interacting stepwise with the pre-mRNA. Most 
mammalian pre-mRNAs contain multiple introns with remarkably variable length 
that range from few bases, to hundreds of thousands of kilobases. Whereas the 
exons have rather fixed average length of only ~120 nucleotides (nts) as compared 
to the introns. However, when an intron's length exceeds ~200-250 nts, the 
formation of the splicing complex initiate across the exon. This particular process 
is known as exon definition. It is evident that serine-arginine rich proteins (SR 
proteins) and heterogeneous nuclear ribonucleoproteins (hnRNP) proteins bind to 
splicing regulatory elements near both the U2- and U12-dependent splice sites and 
help in the recruitment of the respective spliceosome (Lewandowska D. et al., 
2004; Hastings M.L. and Krainer A.R., 2001; Wu Q. and Krainer A.R., 1998; 
McNally L.M., 2006). Being a very dynamic process, splicing complex involves 
various RNA:RNA, RNA:protein, and protein:protein interactions. The splicing 
process begins with the sequential recognition and binding of the 5' splice site and 
the branch site by their complementary snRNAs. After the complete assembly of 
spliceosome across an intron is achieved, two transesterification reactions result 
in the removal of the intron, resulting in the joining of the flanking exons. The 
detailed process of spliceosomal assembly and the mechanism are explained in 
section 1.2. 
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1.2      Two different types of introns and their splicing mechanisms 
 
The 5' splice site (AG/GURAGU), the branch site (CURACU) and the 3’ 
splice site (YAG/G) of U2-dependent introns contain a characteristic sequence 
signature. The adenosine (A) underlined in the branch site sequence has been 
shown to be involved in the nucleophilic reaction. In the U2-dependent introns, the 
branch site sequence and the 3’ splice site sequence are roughly 40 nucleotides 
apart and is pyrimidine rich region hence known as polypyrimidine tract. This 
polypyrimidine region has been shown to be important for the recognition of 
upstream branch site sequence of the intron. RNA-RNA base pair interactions 
occurring between the splice sites of the introns and the snRNAs accounts to the 
specificity of the splicing reaction. In case of U2-dependent intron splicing 
mechanism, the 5' splice site and the branch site are recognized and base paired 
with U1 snRNA and U2 snRNA respectively (Will C.L. and Luhrmann R., 2005). 
In contrast, the U12-dependent introns consensus splice site sequences 
signatures are different from U2- dependent introns. The 5' splice site 
(RTATCCTTT) as well branch site (UCCUUAACU, where the underlined A is the 
branch point adenosine) of U12-type introns are longer and more tightly 
constrained as compared to the U2-type introns. U12-dependent introns do not 
contain polypyrimidine tract. Therefore, the average distance between the U12-
type branch site and the 3’ splice site is significantly shorter (i.e., 11–13 
nucleotides) than that of the U2-type introns (i.e., 18–40 nucleotides) and has been 
demonstrated to be an important determinant for the recognition of U12-dependent 
introns (Hall S.L. and Padgett R.A., 1994; Dietrich R.A. et al., 2001a; Levine A. 
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and Durbin R.A., 2001).  
The U12-dependent introns were named as “atac” introns because they 
were first identified on the basis of their terminal AT–AC di-nucleotides at their 5' 
and 3’ ends respectively (Jackson I.J. 1991; Hall S.L. and Padgett R.A. 1994). 
Later on, with the detailed bioinformatics studies, it was realized that these terminal 
dinucleotides are not exclusive for all the annotated U12-dependent introns (Wu 
Q. and Krainer A.R., 1997). Rather than the terminal di-nucleotides signature, 
highly conserved 5′ splice site and branch point sequences (BPS) are considered 
to be the major determinants of the U12-type intron as compared to U2-type 
introns. Whereas the 3' splice site of U12-type intron is more variable (Jackson I.J., 
1991) (Figure 1). Surprisingly, 70-80% of the total U12-type introns contain GT–
AG terminal di-nucleotide and is actually the more common subtype (Burge C.B. 
et al., 1998). Therefore, a different nomenclature was adopted in which the introns 
are referred to as U2-dependent introns, and the less abundant introns as U12-
dependent introns (Dietrich R. A. et al., 1997). Similarly, the splicing machineries 
which catalyze the removal of U2- or U12-dependent introns are named as U2- or 
U12-dependent spliceosomes respectively. Based on their relative abundance in 
the cell, these spliceosomes are also often referred to as the ‘major’ and ‘minor’ 
spliceosomes respectively (Dietrich R. A. et al., 1997; Sharp P.A. and Burge C.B., 
1997).  
U12-type introns coexist with neighbouring U2-type introns in a host gene. 
Typically, U12-type introns occur one per any given host gene. However, there are 
multiple genes annotated in the U12 Data-Base that are considered to have two 
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or more U12-dependent introns. Human NHE-6 gene has been reported to contain 
three U12-type introns (Levine A. and Durbin, R.A, 2001).  
 
 
 
Figure 1: Consensus splice site sequences of (a) U2-dependent and (b) U12-dependent 
introns. The colored consensus sequences and the size of each letter represents the frequency of 
each base at the 5' and 3’ splice sites respectively of majority of the introns. In case of U2-
dependent introns, GT and AG are the terminal dinucleotides. Whereas for U12-dependent introns 
they could be either AT-AC or GT-AG (Padgett R.A., 2012).  
 
 
1.2.1   Mechanism of U2-dependent intron splicing 
 
 
The efficient and precise interactions of splicing factors with the consensus 
pre-mRNA signature sequences plays most important role in the assembly of the 
complete spliceosomal complex. The reactive groups of the pre-mRNA such as 
the 5' splice site, the branch point adenine, and the 3’ splice site are spatially 
positioned in such a way to efficiently catalyze the removal of an intron by 
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sequential transesterification reactions. Several conformational rearrangements of 
the small nuclear ribonucleoproteins (snRNPs) within the ribonucleoprotein 
complex result in this proper spatial positioning of all the splice sites. 
The assembly of U2-dependent spliceosome is achieved by the 
involvement of the U1, U2, U5, and U4/U6 snRNPs as well as numerous other 
splicing factors. The process of spliceosomal assembly on pre-mRNA and 
formation of active catalytic complex involves highly dynamic RNA-RNA base pair 
interactions between pre-mRNA:snRNA and snRNA:snRNA (Nilsen T.W., 1998). 
This complex, dynamic, and multistep process involves the formation of sequential 
complexes known as E, A, B, B*, and C (represented in Figure 3) (Reed R. and 
Palandjian L., 1997). The initial step involves the recognition and interaction of the 
U1 snRNA at the 5' splice and formation of the commitment complex or E complex. 
The proteins that are specifically associated with the U1 snRNA, such as U1-70K 
and U1-C, facilitate and stabilize the interaction between the 5' splice site 
sequence and the U1 snRNA (Will C.L. and Luhrmann R., 1997). In the following 
step, the U2 snRNA and its associated proteins interacts with the branch site, 
forming the A complex. The U2 snRNA associated proteins such as SF3a and 
SF3b interact with the pre-mRNA at or near the branch site sequence and enhance 
the stabilization of U2 snRNA interactions with the branch site (Reed R., 1996; Will 
C.L. and Luhrmann R., 1997). After the formation of A complex, the U4, U6 and 
U5 snRNAs interact with each other to form a U4.U6/U5 tri-snRNP complex. In this 
tri-snRNP complex, the U6 and U4 interact by RNA-RNA and U5 by RNA protein 
interactions.  This U2-dependent spliceosome specific tri-snRNP complex 
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associates with the existing splicing complex, resulting in the formation of complex 
B. At this step, the snRNAs undergo major structural and spatial rearrangements 
which further lead to the formation of catalytically active complex B*. During this 
step, the RNA-RNA base-pair interactions between U4/U6 are disrupted and as a 
consequence of these structural rearrangements, the U1 snRNA interactions with 
the 5' splice site and U4 snRNA interactions with the U6 within the spliceosome 
are destabilized and, hence both the snRNAs dissociate from the spliceosome 
(Will C. L. and Luhrmann R., 2005). 
After the release of U1 snRNA, U6 snRNA interacts with and occupies the 
5' splice site. After the release of U4 snRNA, a region of U6 snRNA forming stem-
I and stem-II rearranges into an intramolecular stem-loop (U6-ISL) structure, that 
is positioned very close to the catalytic site of U2-type splicing and is implicated in 
the catalysis of splicing. In addition, the U5 snRNA works as a tethering snRNA by 
interacting nucleotides of the exon both near the 5' splice site and the 3' splice site. 
Subsequently, the first catalytic step of splicing occurs and the C complex is 
generated. The active catalytic core complex involves only three snRNAs including 
U6, U2, and U5 for U2-dependent spliceosome. At this step, with the help of two 
sequential transesterification reactions (Figure 2) the intron is removed as lariat 
structure and the 5' and 3' exons are joined together. After the second catalytic 
step, the components of the spliceosome dissociate resulting in the release of the 
mRNA and the excised intron, as well as the snRNPs, which are recycled to take 
part in new rounds of splicing (Will C. L. and Luhrmann R., 2005; Chen H.C. 
and Cheng S.C., 2012). Despite the fact that spliceosomal proteins predominantly 
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comprise the major composition of the spliceosome, which also play important role 
in the activation of the spliceosome, but the catalysis of pre-mRNA intron splicing 
appears to be completely RNA-based where U2 and U6 snRNAs playing the 
pivotal role (Collins C. A.  and Guthrie C., 2000).      
 
 
 
Figure 2: Two step trans-esterification reaction involved in pre-mRNA splicing. The 
conserved splice site sequences are shown in red. The splicing reaction takes place in two steps. 
The first step involves the cleavage of the 5' splice site resulting in the formation of lariat intron and 
Exon 2 with the help of 2’-5' phosphodiester linkage. The second step is the cleavage at the 3' 
splice site and the ligation of the two exons. (Chen H.C. and Cheng S.C., 2012). 
  Two-step transesterification reaction of pre-mRNA  
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1.2.2   Mechanism of U12-dependent intron splicing 
 
The U12-dependent spliceosome includes U11, U12, U5, and 
U4atac/U6atac snRNPs as well as numerous non-snRNP proteins (Hall S.L. and 
Padgett R.A., 1996; Tarn W.Y. and Steitz J.A., 1996 a, b). These snRNAs are the 
functional analogs of the snRNAs catalyzing U2-dependent splicing (Hall S.L. and 
Padgett R.A., 1996; Tarn W.Y. and Steitz J.A., 1996a, b; Kolossova I. and Padgett 
R.A., 1997; Yu Y.T. and Steitz J.A., 1997; Incorvaia R. and Padgett R.A., 1998). 
Thus, among all the spliceosomal snRNAs, only U5 is common between both the 
spliceosomes. Assembly of the U12-dependent spliceosome is almost similar to 
that of the U2-dependent spliceosome, with a major difference occurring at the 
initial step (Figure 3). Prior to the recognition and their interactions with the pre-
mRNA, the U11 and U12 snRNAs interact with each other and form a highly stable 
di-snRNP complex that binds in a cooperative manner to the 5' splice site and the 
branch site, respectively during the first step of the minor spliceosome assembly 
(Wassarman D.A. and Steitz J.A., 1992; Frilander M.J. and Steitz J.A., 1999). 
Therefore, in contrast to the major spliceosome, the earliest assembly step 
involves the formation of the A complex with missing commitment E complex. In 
the subsequent step, the U4atac.U6atac/U5 tri-snRNP complex interacts with the 
A complex and results in the formation of the B complex (Tarn W.Y. and Steitz 
J.A., 1996 a,b). Similar to the U2 dependent spliceosome, activation of the minor 
spliceosome also involves the destabilization of the U11 and U4atac snRNPs. The 
role of the U4 or U4atac snRNA is thought to be that of a chaperone by 
sequestering the U6 or U6atac snRNA via extensive base-pairing interactions prior 
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to catalytic activation of the spliceosome (Guthrie C. and Patterson B., 1988; Tarn 
W.Y. and Steitz J.A., 1996a). The remaining steps appear to be similar to those 
involved in the U2-dependent spliceosome such as the formation of a C-like 
complex at the time of the first transesterification reaction followed by dissociation 
of the minor spliceosomal components after the second transesterification. Recent 
studies have revealed that at the time of A complex formation, the nucleotides at 
the 5' end of U12 snRNA also transiently interact with exon nucleotides just 
upstream of the 5' splice site (Frilander M.J. and Meng X., 2005). These 
interactions are destabilized when the U4atac.U6atac/U5 tri-snRNP joins the 
spliceosome. Thus, during the early stages of minor spliceosome assembly, U12 
can simultaneously interact with both the branch site as well as nucleotides of the 
pre-mRNA near the 5' splice site. Upon integration of the minor U4atac.U6atac/U5 
tri-snRNP, the U4atac and U6atac base-pairing interaction is disrupted. The 
U6atac then interacts with the 5' splice site (displacing U11) and also with the 5' 
end of the U12 snRNA, whereas the U5 snRNA interacts with exon nucleotides 
near the 5' splice site and, at later stage, with exon nucleotides near the 3' splice 
site (Figure 3; Tarn W.Y. and Steitz J.A., 1996a, b; Yu Y.T. and Steitz J.A., 1997; 
Incorvaia R. and Padgett R.A., 1998; Frilander M.J. and Steitz J.A., 2001). The 
intermolecular structures formed by the pre-mRNA and the U12, U5, and U6atac 
snRNAs appear to be similar to those formed by their counterpart snRNAs involved 
in the U2-dependent spliceosome (Figure 3). Similar to the U6-intramolecular 
stem-loop structure, U6atac also forms an intramolecular stem loop structure with 
similar significance in the catalysis of intron removal. It has been shown that the 
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first step of the pre-mRNA intron splicing catalysis is mediated by the metal ion 
along with a nucleotide in the intramolecular stem-loop structure of U6 or U6atac 
snRNA. This secondary structure resembles the catalytically active structure of the 
domain 5 of self-splicing group II introns which self-splice without involving any 
protein (Gordon P. M. et al., 2000; Keating et al., 2010), thus indicating that 
spliceosome is an RNA-enzyme (a ribozyme) where the active site is composed 
of RNA molecules (Sashital et al., 2004).   
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Figure 3: Spliceosome assembly (Left panel: U2-dependent spliceosome. Right panel: U12-
dependent spliceosome). Schematic representation of the interaction of the spliceosomal 
snRNPs at various stages of the dynamic process. The different stages and complexes are 
depicted as E, A, B*, and C for both the U2- and U12-dependent spliceosomes (Turunen J.J. et al., 
2012). 
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1.3      Predicted secondary structures of U12-dependent snRNAs 
 
  Thus far, we know that both types of spliceosomes involve the set of four 
unique and one common snRNA. Although the sequences of these analogous 
snRNAs involved in two different spliceosomes are quite divergent but to some 
extent they share a common overall secondary structures (Figure 4). Both the RNA 
as well as protein composition of U4atac.U6atac/U5 tri-snRNP of U12-dependent 
spliceosome appear to be very similar to that of U4.U6/U5 tri-snRNP complex 
involved in U2-dependent spliceosome (Schneider C. et al., 2002). Interestingly, it 
has also been demonstrated that both the U4 and the U4atac snRNAs from 
different spliceosome form equivalent secondary stem-loop structures which serve 
as binding platforms for the proteins that are essential for the formation of the tri-
snRNP complex (Schneider C. et al., 2002; Nottrott S. et al., 2002). Furthermore, 
U1 and U2 snRNAs are available as distinct snRNPs and interact with the pre-
mRNA in a sequential manner. Whereas, their counterparts (U11 and U12 
snRNAs) are always bound to each other by specific RNA-protein interactions in 
the nucleus as a U11/U12 di-snRNP complex and interact with pre-mRNA in a 
cooperative manner (Wassarman K.M., 1992; Montzka K.A. and Steitz J.A., 1988). 
Shukla G. C. and Padgett R. A. (1999) have shown that the U12 and U6atac 
snRNAs of U12-dependent spliceosome share an overall structure as well as many 
of the sequences similarity to their highly conserved counterpart U2 and U6 
snRNAs of U2-dependent spliceosome. In this report, the group identified the 
homologs of U6atac and U12 snRNAs in Arabidopsis thaliana. Higher percentage 
of conservation of sequence and structures for U6atac (65%) and for U12 (55%) 
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snRNA, suggest that these snRNAs in plants are significantly diverged from the 
human. The U6atac nucleotides of A. thaliana that base pair with the 5' splice site 
sequence of U12-dependent introns shows complete sequence conservation to 
that of Human U6atac (Shukla G. C. and Padgett R. A., 1999)).  
 These snRNAs contain a conserved single stranded sequence, normally 
flanked by two stem-loop structures, known as Sm-site with consensus of PuAU4-
6 (where Pu is purine). These Sm sites provide the binding platform for Sm-proteins 
(Will C. L. and Luhrmann R., 2001).    
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Figure 4: The predicted secondary structures of the human spliceosomal snRNAs. Different 
regions of the snRNAs have been highlighted in different colors. Same color coded regions have 
been shown to interact with each other during the process of splicing. The binding sites for Sm 
proteins are shaded in gray, and the sequences interacting with the 5′ss or BPS is shaded in cyan. 
U2/U6 or U12/U6atac interacting sequences are indicated by green (helix I), purple (helix II), and 
yellow shading (helix III). Nucleotides highlighted in red show the position of the microcephalic 
osteodysplastic primordial dwarfism type I (MOPD1) mutations in the U4atac snRNA (Turunen J.J. 
et al., 2012). 
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 Similar to those U1, U2, and U4 snRNAs catalyzing U2-dependent intron 
splicing, their counterparts snRNAs such as U11, U12, and U4atac along with U5 
snRNA possesses 2,7,7 tri-methylguanosine 5' cap structure. Whereas, U6atac 
(and U6) has monomethyl phosphate cap and lacks Sm-binding site (Tarn W.Y. 
and Steitz J.A. 1996a). 
 
1.4    RNA-RNA base-pair interactions in the catalytic core complex of   
spliceosomes  
  Although the formation of the catalytic core appears to be somewhat more 
flexible in the U12-dependent as compared to the U2-dependent spliceosome, the 
structure and function of both the core complexes appear to be very similar 
(Frilander M.J. and Steitz J.A., 2001). Moreover, both spliceosomes involve the 
same sequential two-step transesterification reaction mechanism for the removal 
of an intron (Tarn W.Y. and Steitz J.A. 1996) (Figure 2). Similar RNA-RNA base 
pair interactions can be drawn among U12, U6atac, U5, and with the U12-
dependent intron in the active catalytic core of the U12-dependent spliceosome to 
those happening in the components of the major spliceosome. The RNA-RNA 
base pair interactions between U2 and U6 snRNA which form the helix II structure 
is specific to the major spliceosomal complex. However, similar U12-U6atac 
intermolecular interactions between these two molecules has not yet been 
validated in the minor spliceosome (Figure 5). The predicted helix III formed by 
U12 and U6atac interactions is still not yet validated and it is not conserved in 
plants (Shukla G.C. and Padgett R.A., 1999), but reduced splicing activity in 
mammals was observed when mutations were introduced in this region of U12 
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snRNA that weakens the helix III structure (Sikand K. and Shukla G.C., 2011). 
Furthermore, it is suggested that these mutations could possibly be interfering with 
the RNA-RNA base pair interactions resulting in the formation of the predicted helix 
III in the U12-dependent catalytic core complex. In addition, the structural domain 
similarity of snRNAs between the two distinct spliceosomes suggest that the minor 
spliceosome is likely to involve RNA-based catalysis, similar to major spliceosome 
(Valadkhan S. et al., 2009).   
 
 
 
 
 
Figure 5: RNA–RNA base-pair interactions occurring in the active catalytic cores of U12- 
and U2-dependent spliceosomes. The boxes with the dark outline represent the 5' and 3' exons. 
U6 or U6atac interactions at the 5' splice site and U2 or U12 interactions at the branch site of the 
introns are shown in cyan. The helix I region formed by the RNA-RNA base pair interactions 
between U2/U6 and U12/U6atac have been highlighted in green. Purple and yellow shading 
represent the formation of helix II and helix III respectively. (Turunen J.J. et al., 2012). 
 
 
1.5      U11/U12 di-snRNP complex, specific and shared proteins   
 
The protein compositions of the major snRNPs and the spliceosome formed 
by these snRNPs are very well characterized. Due to the fact that the U12-
dependent snRNPs are 100 times less abundant in the cell as compared to their 
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counterparts U2-dependent snRNAs (Yu Y.T. et al., 1999), our comprehensive 
knowledge about the protein composition involved in the minor spliceosome is still 
far from complete.   
Characterization of the human U11/ U12 di-snRNP and U4atac/U6atac.U5 
tri-snRNP complexes revealed most of the identified proteins present in the minor 
spliceosome, indicating that many snRNP-associated proteins are shared by both 
the spliceosomes. The sharing of the protein components by the two spliceosomes 
is consistent with the conserved catalytic mechanisms of both spliceosomes. To 
date, only seven (65K, 59K, 48K, 35K, 31K, 25K and 20K) (Figure 6) protein 
components, specific to U12-dependent spliceosome, have been identified. All the 
seven protein were found to be associated with the 18S U11/U12 di-snRNP 
complex (Will C.L. et al., 2004; Will C.L. et al., 1999). The lack of all the U1 
associated specific proteins and some of the U2-associated proteins in U11/U12 
di-snRNP complex makes it the most divergent component of the minor 
spliceosome so far (Will C. L. et al., 2001).  
Four proteins (i.e., 59K, 48K, 35K, and 25K), out of seven U11/U12 di-
snRNP specific associated proteins, were found in affinity-selected 12S snRNPs 
enriched in U11 (Will C.L. et al., 2004). Association of the 59K, 35K, and 25K 
proteins with the U11 snRNA was further confirmed by immunoprecipitation 
studies. Thus, the U11 snRNP is comprised of at least four novel proteins, three 
of which (59K, 48K, and 25K) bear no resemblance to the U1-70K, U1-A, and U1-
C proteins found in the U1 snRNP (Will C.L. and Luhrmann R.1997). 
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Furthermore, because only one of the U11-associated proteins (i.e., 35K) 
contains a RNA recognition motif known to mediate RNA binding, it is likely that 
only one of the stem–loop structures of the U11 snRNA is bound to protein. These 
observations suggest that within the U11 snRNP, stem–loop III is bound by the 
35K protein. There are evidences that suggest that the remaining U11-proteins 
associate in the U11/U12 do-snRNP complex via protein-protein interactions (Will 
C.L. et al., 2004). 
 
  
 
Figure 6: Protein composition of the human U2- and U12-dependent snRNPs. The presence 
of a given protein in a snRNP is indicated by a colored circle. Mass spectrometry revealed the 
presence of seven U12-dependent spliceosome specific proteins in purified human 18S U11/U12 
snRNPs. These proteins are represented with purple colored circles. Four (25K, 35K, 48 and 59 K) 
out of seven are associated with 12S U11 snRNPs. (Will C.L. et al., 2004). 
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1.6      Phylogenetic conservation of U12-dependent spliceosome 
The significant similarities related to the structure of different components 
and the mechanism involved by the two distinct spliceosomes suggest that both 
machineries are evolved from common ancestry. Putative U12-dependent introns 
can be recognized computationally on the basis of their conserved 5′ splice site 
and the branch site sequence signatures. Using different computational tools, U12-
dependent RNAs (including introns as well as the snRNAs, catalyzing the intron 
splicing) were identified in a diverse range of phylogenetically distant species such 
as Fungi, Acanthamoeba/Mycetozoa and Streptophyta. Presence of U12-
dependent introns and the splicing machinery in the lower eukaryotes strongly 
supports the notion that the U12-dependent spliceosome pre-existed the U2-
dependent spliceosome. The two different theories, among many, which can 
explain the presence of U12-dependent introns as only a handful of total introns 
exhibited by the highly evolved human genome is either the complete loss of U12- 
type intron or the conversion of less efficient U12-type introns to more efficiently 
spliced U2-type introns over a period of time (Russell A.G. et al., 2006; Dietrich 
R.C. et al., 1997).  
In contrast with U2-dependent introns, which are ubiquitously distributed 
among all the eukaryotes, the presence of U12-dependent introns has so far only 
been identified in vertebrates, insects, cnidarians, Rhizopus 
oryzae, Phytophthora and Acanthamoeba castellanii (Burge C.B. et al., 1998). 
Surprisingly, the genome of the budding yeast Saccharomyces cerevisiae and the 
nematode Caenorhabditis elegans do not contain any U12-dependent introns or 
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components of the spliceosome (Burge C.B. et al., 1998; Russell A.G. et al., 2006; 
Mewes H.W. et al., 1997).  Both the computational as well as experimental 
analyses in depth identified a large number of spliceosomal RNAs from different 
organisms. However, there are certain phylogenetic groups in which spliceosomal 
RNAs were not identified at all (Dietrich R.C. et al., 1997; Griffiths-Jones S, 2007) 
(Figure 7). 
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Figure 7: Schematic of a phylogenetic tree indicating where U12 introns were lost. 
Phylogenetic groups and their relationships have been shown together with example species. 
Species where one or more U12-dependent spliceosomal RNAs were found are highlighted in red 
circles as well as branches where the U12-type RNAs seem to have been lost are shown with 
dotted lines. Numbers at branches indicate 1) number of genomes analyzed, 2) number of query 
sequences used and 3) number of new sequences identified. (Lopez M.D. et al., 2008). 
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1.7      Slower kinetics of U12-dependent intron splicing regulates global gene 
expression  
Both types of introns are removed cotranscriptionally in the nucleus (Singh 
J. and Padgett R.A., 2009) with almost similar splicing mechanism but with 
different kinetics. However, the rate of removal of U12-dependent intron is 
significantly slower. In vitro splicing experiments suggested a three to five-fold 
slower rate of U12-type intron splicing as compared to U2-type introns (Frilander 
M.J. and Steitz J.A.., 1999; Tarn W.Y. and Steitz J.A., 1996; Santoro B. et al., 
1994). However, only two-fold higher accumulation of unspliced U12-dependent 
introns were detected in vivo in the steady-state transcript pools.  
Further studies have shown that by converting U12-dependent intron to the 
U2-dependent intron in a protein coding transcript can increase the expression of 
the protein by almost six-folds (Santoro B. et al., 1994; Pessa H.K., 2006; Patel 
A.A. et al., 2002). The factors contributing to the slower rate of the minor 
spliceosome could be the relative lesser (100 fold less) abundance of the snRNPs 
as compared to the major snRNPs (Montzka K.A. and Steitz J.A., 1988; Tarn W.Y. 
and Steitz J.A., 1996). It is also hypothesized that high conservation of the splice 
sites might be resulting in rigid recognition of U12-dependent introns and therefore, 
linked to the slower kinetic rate of intron splicing. Regardless of the underlying 
mechanism, the slower rate of splicing of U12-dependent introns contribute to the 
rate-limiting mechanism for the expression of host genes (Patel A. A. et al., 2002). 
The transcripts with the unspliced U12-dependent intron are unable to escape the 
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nucleus and hence are targeted by nuclear surveillance mechanisms (Patel A. A. 
et al.,2002; Younis I. et al., 2013). 
 
 
 
 
Figure 8: Schematic representation of rate-limiting regulation of gene expression by U12-
type introns. Exons are indicated with a red color, U2-dependent introns are indicated in light gray, 
and U12-dependent introns are represented in dark gray. Similar to the U2-dependent introns, U12-
dependent introns are also spliced co-transcriptionally. A majority, or all, U12-dependent introns 
are correctly recognized by the U11/U12 di-snRNP, and most likely can also assemble 
spliceosomal complexes. However, a subset of them fails to carry out the splicing reaction and is 
targeted by the nuclear quality control mechanisms. Alternatively, it is possible that this subset can 
be spliced more slowly post-transcriptionally (Niemela E. H. and Frilander M. J., 2014). 
 
 
Stabilization of the transcripts hosting unspliced U12-dependent introns has 
been demonstrated upon knocking-down of the nuclear exosome. This 
observation clearly indicates that transcripts containing unspliced U12-dependent 
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introns are actively degraded by the nuclear quality control machinery (Figure 8). 
Together, these two observations strongly support for the rate-limiting control 
hypothesis which states that U12-dependent introns limit the expression levels of 
their host genes. Most likely the degradation activity is linked to nuclear retention 
whereby a delay in processing increases the probability of mRNA degradation, as 
suggested by the kinetic surveillance hypothesis of nascent pre-mRNAs (Burgess 
S.M. and Guthrie C., 1993; Doma M.K. and Parker R., 2007). Recently, it has been 
evident that the surveillance mechanisms are actively recruited to transcripts 
containing unspliced introns through interactions between the components of the 
stalled spliceosome and the nuclear quality control machinery (Nag A. and Steitz 
J.A., 2012). 
The less abundant U6atac snRNP (approx. 2000 copies/cell) is strikingly 
unstable with a shorter half-life (t½<2 hr). The expression of U6atac snRNA 
depends on both RNA polymerases II and III, which can be rapidly enhanced by 
cell stress-activated kinase (p38MAPK), thus resulting in stabilization of U6atac. 
p38MAPK kinase mediated stabilization of U6atac further enhances downstream 
mRNA expression of genes containing minor introns which are otherwise 
suppressed by limiting U6atac snRNA. Interestingly, the minor intron-containing 
tumor suppressor PTEN (Phosphatase and Tensin Homolog) expression also 
depends upon p38MAPK-dependent U6atac mediated regulation. Therefore, 
minor class introns are considered as embedded molecular switches regulated by 
U6atac abundance (Younis I. et al., 2013). 
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1.8    Chimeric snRNAs can functionally activate in vivo U12-dependent 
intron splicing 
The functional cores of U6 snRNA of U2-dependent and U6atac snRNA of 
U12-dependent spliceosomes are highly similar in sequence and are functionally 
interchangeable. Experimental evidences have demonstrated that a chimeric U6 
snRNA generated by fusing the unique and highly conserved 3′ end of U6atac 
snRNA could efficiently activate the in vivo U12-dependent intron splicing (Figure 
9). Furthermore, deletions of the 3' end of U6atac snRNA in vivo, as well as in vitro 
antisense experiments, suggested that the 3′ end of U6atac snRNA has U12-
dependent spliceosome specific guiding activity for the U4atac.U6atac/U5 tri-
snRNP complex, therefore directing the complex to the U12-dependent 
spliceosome (Dietrich R.C. et al., 2009). 
 
 
 
Figure 9: RNA-RNA base-pairing interactions of the chimeric U6/U6atac snRNA with the 
modified U4atac snRNA. The chimeric snRNA consists of U6 nucleotides 1–79 joined to U6atac 
nucleotides 52–125 (3′ stem–loop region shown within the box). Nucleotides at positions U40, A41, 
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and C42 were replaced by the sequence AACC, which are known to base pair with the mutant 5' 
splice site of U12-dependent intron F of P120 minigene. Mutations were introduced in the U4atac 
snRNA so that it can form Stem I and Stem II base pairing with chimeric U6/U6atac (Dietrich R.C. 
et al., 2009). 
  
U4 and U6 snRNA form a base-paired di-snRNP complex that is essential 
for pre-mRNA splicing of the U2-dependent introns. The functionally analogous but 
highly diverged U4atac and U6atac snRNAs which are involved in splicing of U12-
dependent introns also form a similar complex. It has been shown earlier that wild-
type U4 snRNA interacts with the mutant U6atac snRNA (Shukla G. C. and Padgett 
R. A., 2001). Recent evidence shows that a mutant U4 snRNA designed to base 
pair with a mutant U6atac snRNA can activate U12-dependent splicing when co-
expressed in an in vivo genetic suppression assay (Shukla G. C. and Padgett R. 
A., 2003). These potential interactions between U4 and U6atac snRNAs were also 
demonstrated by an in vitro crosslinking assay, suggesting that a U4/U6atac di-
snRNP can be recruited to the U12-dependent spliceosome which could efficiently 
and precisely splice the U12-dependent intron. Moreover, it has been shown that 
the spliceosome type specificity is exhibited by U6 and U6atac snRNAs (Shukla 
G.C. and Padgett R.A., 2004).  
  Surprisingly, there is an evidence that the U6atac-ISL can be functionally 
replaced either by U6-ISL either from humans or from budding yeast (Shukla G.C. 
and Padgett R. A., 2001) (Figure 10). This demonstrates that an important 
substructure of the spliceosomal RNAs can be functionally substituted by the other 
between the two distinct splicing systems. Therefore, supporting both the 
significance of these similar elements, as well as the notion that these elements 
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are derived from parallel but distinct splicing systems in ancestral prokaryotic 
genomes that might have combined during the genesis of the eukaryotic lineage 
(Burge C.B. et al., 1998).  
 
Figure10: Intramolecular stem-loop structures of various U6 and U6atac snRNAs. The left 
panel shows the sequence of Human U6atac forming intramolecular stem-loop (ISL) structure. The 
middle and the right panel represent the sequences of ISL from Human and yeast U6 snRNA. The 
Human U6 and yeast U6 ISL were substituted into the human U6atac snRNA (Shukla G.C. and 
Padgett R. A., 2001). 
 
  The first step of the catalytic reaction involved in the pre-mRNA intron 
splicing is mediated by the metal ion and a nucleotide in the intramolecular stem-
loop structure of either U6 or U6atac snRNA. The secondary structure of ISL 
resembles the catalytically active structure of the domain 5 of self-splicing group II 
introns. Thus indicating that spliceosome is a ribozyme, where the active site is 
composed of RNA (Sashital et al., 2004).  
U6atac and U12 snRNAs have been shown to interact with each other, as 
well as with the pre-mRNA by RNA-RNA base-pair interactions. The overall 
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secondary structures and many of the sequences are very similar to the highly 
conserved analogous regions of U6 and U2 snRNAs of U2-dependent 
spliceosome. The homologs of U6atac and U12 snRNAs in the plant Arabidopsis 
thaliana are significantly diverged in terms of overall sequence similarities from 
human. However, the sequences and structures which are involved in the splicing 
i.e. 5' splice site, branch site, intramolecular stem-loop structure and helix 1a and 
1b regions formed by RNA-RNA base pair interactions between U12 and U6atac 
snRNAs are almost completely conserved. The intramolecular stem-loop structure 
formed by U6atac snRNA, after the U4atac snRNA is released, differs from the 
human sequence. This chimeric snRNA generated by transplanting this stem-loop 
into human U6atac was functionally inactive for in vivo U12-dependent intron 
splicing. However, the coexpression of a U4atac snRNA expression construct 
containing compensatory mutations that restored base pairing to the chimeric 
U6atac snRNA was able to restore the U12-dependent intron splicing (Shukla G.C. 
and Padgett R. A., 1999).   
Interestingly, the interchangeability of D5, a catalytically active domain of 
the group II intron sequence and the intramolecular stem loop of U6atac formed in 
the catalytic core of the U12-dependent spliceosome, has been demonstrated 
(Shukla G.C. and Padgett R. A., 2002) (Figure 11). This suggests that a catalytic 
RNA structure lies at the heart of the spliceosome and shares an evolutionary 
history with group II introns. Taken together, these results clearly indicate that the 
catalysis of U12-dependent intron splicing proceeded by an identical RNA-based 
mechanism. Thus, mechanistic differences between U2- and U12-dependent 
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splicing appear to be limited to early intron recognition events, rather than to 
catalysis.  
 
Figure11: Similar RNA structures in the U12-dependent Spliceosome and Group II Self-
Splicing Introns. (A) RNA-RNA interactions in the catalytic core of U12-dependent spliceosome. 
The nucleotides which are mutated in the pre-mRNA and the U11 and U6atac snRNAs in order to 
perform the in vivo mutation suppression assay are highlighted in the dark box. The U11 and 
U6atac snRNA contains compensatory mutations to the ones introduced at the 5' splice site of the 
U12 dependent intron. The sequence of the U6atac-ISL has been shown. (B) Secondary structure 
of a group II intron showing the six domains. The sequence of the domain 5 is shown (Shukla G.C. 
and Padgett R. A., 2002).  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1.9   P65 is highly conserved and an essential component of U11/U12 di-
snRNP complex 
  Recently, recessive lethal point mutation in the RNA binding protein rnpc3 
[RNA-binding region (RNP1, RRM) containing 3] gene has been associated with 
severe developmental arrest of digestive organs in zebrafish. The rnpc3 expresses 
the zebrafish ortholog of human RNPC3 which is also recognized as the U11/U12 
di-snRNP 65-kDa protein, and is one of the unique protein components of the U12 
spliceosome specific U11/U12 di-snRNP complex. This mutation in the rnpc3 gene 
is considered to interfere in the formation of the U11/U12 di-snRNP complex, 
therefore, resulting in impaired efficiency of U12-dependent intron splicing. 
Furthermore, it was suggested that the retention of the intron resulted in differential 
gene expression of multiple genes involved in various important cellular steps of 
mRNA processing such as transcription, splicing, and nuclear export are 
compromised in mutant zebrafish (Sebastian M. et al., 2014). 
The functional role of a U12-dependent spliceosomal specific protein, 
U11/U12-65K in Arabidopsis thaliana, has been characterized. The miRNA-
mediated transgenic knockdown generated plants showed severe growth and 
developmental defects. Experiments revealed compromised splicing of majority of 
predicted U12-dependent intron-containing genes in the U11/U12-65k mutant 
(knockdown). The U11/U12-65K is very conserved among different species 
(Figure 12) and its mutation also interferes with alternative splicing. The genes 
involved in cell wall biogenesis and function, plant development, and metabolic 
processes were the ones which were greatly affected in the mutant plant. 
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U11/U12-65K protein binds specifically to the highly conserved stem loop III of U12 
snRNA (Benecke H. et al., 2005), which is necessary for branch site recognition. 
These results clearly demonstrate that U11/U12-65K is an essential component of 
the minor spliceosome, and plays a vital role in both U12- dependent intron splicing 
as well as in regulation of alternative splicing events of many introns, which are 
crucial for plant development (Jung H.J. and Kang H., 2014). 
 
 
 
Figure 12: The U11/U12 di-snRNP specific 65K protein is evolutionarily conserved. Sequence 
alignment of 65K from H. sapiens and putative orthologs from M. musculus, X. laevis, A. 
thaliana and D. melanogaster. Residues identical in at least three proteins are highlighted in black 
and conserved residues are highlighted in gray. The RNA recognitions motifs are indicated by a 
bar on the top. The conserved sequence QVLHLMN(K/R) MNL is marked by dots (Benecke H. et 
al., 2005). 
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1.10  U12 Stem-loop III is indispensable for in vivo U12-dependent intron 
splicing 
In both the spliceosomes U2 and U12 snRNAs interact with the branch site. 
U12 snRNA is a functional analog of U2 snRNA of the U2-dependent spliceosome 
and is essential for the splicing of U12-dependent introns. Recently, the secondary 
structures or regions of U12 snRNA which are outside of the branch site base 
pairing region are analyzed, and the functional requirement of these structures or 
elements in U12-dependent intron splicing has been studied in detail. The intricate 
predicted secondary structure of U12 snRNA contains several stem-loops 
separated by single-stranded regions (Figure 13). Data from the well characterized 
genetic suppression assay demonstrated that stem-loop IIa is an essential element 
and is required for in vivo U12-dependent intron splicing. Surprisingly, an 
evolutionarily conserved stem-loop IIb was found to be dispensable for in vivo U12-
dependent intron splicing. Also, the stem-loop III, which has been shown to provide 
an interacting platform for C-terminal RNA recognition motif of p65 (Benecke H. et 
al., 2005) of the U11/U12 di-snRNP complex, is indispensable for in vivo U12-
dependent intron splicing (Sikand K. and Shukla G.C., 2011) (Figure 13). 
 
37	
	 	
 
 
 
Figure 13: Predicted secondary structure of human U12 snRNA. The structure is based on the 
earlier predicted models. SLI, SLIIa, SLIIb, SLIII represent the four different stem-loop structures. 
SLIII-THL, MH and LH are the Terminal Helix and Loop, Middle Helix and the Lower Helix of stem 
loop III. Nucleotides 1–13 in SLI highlighted in light grey are predicted to interact with U6atac 
snRNA. Nucleotides 18–24, highlighted in dark grey SLI bind to branch site of a U12-dependent 
intron. The predicted Sm site is also indicated in grey shade between SL IIB and SL III (Sikand K. 
Shukla G.C., 2011).  
 
 
1.11    U12 Stem-loop III interacts with C-terminal RRM of 65K protein 
 
U11 and U12 snRNAs interact with each other to form a stable U11/U12 
18S di-snRNP complex. This complex interacts with the pre-mRNA, in a 
cooperative manner, at the 5' splice site and the branch site, thereby acting as a 
molecular bridge between the 5' and 3' ends of the intron within the U12-dependent 
pre-spliceosome. By performing detailed in vitro RNA-protein interaction 
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experiments, it has been demonstrated that the U11/U12-65K protein interacts 
directly with the U12 snRNA stem loop III via its C-terminal RRM and with the U11-
associated 59K protein via its N-terminal half (Benecke H. et al., 2005) (Figure 14). 
The 3' end of U12 snRNA forms an extended stem-loop with a highly conserved 
terminal seven-nucleotide loop. This stem-loop III of U12 snRNA also serves as 
the 65K binding site. The addition of an oligonucleotide designed to express the 
interacting site for 65K to an in vitro splicing reaction inhibited U12-dependent. 
However, the U2-dependent pre mRNA splicing was not affected at all. Taken 
together, these data suggest that U11/U12-65K and U11-59K contribute to di-
snRNP formation and intron bridging in the minor pre-spliceosome (Benecke H. et 
al., 2005). 
 
 
 
 
 
Figure 14: Schematic of the human U11/U12 di-snRNP complex. 65 K interacts with U12 
snRNA via c-terminal RRM and acts as a bridging molecule with U11 snRNA through 59 K protein. 
Branch point sequence (BPS); “A” represents the branch point adenosine (Sebastian M. et al., 
2014). 
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In this study we observed structural and sequence similarities between the 
distal 3' stem-loop of U6atac and stem-loop III of U12 snRNA. After successfully 
demonstrating the interchangeability of the substructures of the two snRNAs, we 
provided the evidence that the C-terminal RNA recognition motif of p65, a U12 
snRNA binding protein, also interacts with the distal 3′ stem-loop of U6atac. By 
using well characterized genetic suppression assay we demonstrated the 
functional requirement of the distal 3' stem-loop of U6atac in U12-dependent in 
vivo splicing. Furthermore, we also tested the compatibility of the U6atac 3' end 
from phylogenetically distant species in a human U6atac suppressor background 
to establish the evolutionary relatedness of these structures and in vivo 
functionality. Although the significance of p65 interaction to U6atac snRNA in in 
vivo splicing is not clear, we have suggested that both the helix structure, as well 
as the sequence of U6atac distal 3' stem-loop is important for snRNA-protein 
interactions and U12-dependent intron splicing.                   
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Chapter II 
 
MATERIALS AND METHODS 
 
 
 
2.1      Cell culture 
 
Human Hela cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics. CHO-
K1 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 5% FBS, 2 mM L-glutamine, 1 mM L-proline, 10 mM 4-(2-
Hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) and antibiotics. All cell 
lines were maintained in a humidified 5% CO2 atmosphere at 37 0C. Hela and 
CHO-K1 cells were obtained from ATCC (Manassas, VA). 
 
2.2      Construction of snRNA expression plasmids 
  The U11 GG6/7CC, U6atac GG14/15CC and U12 GA23/24CU expression 
plasmids have been described previously (Hall S.L. and Padgett R.A., 1996; 
Kolossova I. and Padgett R. A., 1997; Incorvaia R. and Padgett R. A., 1998; Shukla 
G. C. et al.,  
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2002; Brock J. E. et al., 2008). Second site mutations were introduced in U6atac 
GG14/15CC and U12 GA23/24CU snRNAs to construct swapped SL snRNA 
plasmids and U6atac distal 3′ SL mutant plasmids. The swapped SL snRNA 
plasmids included two modified plasmids, namely, U6atac GG14/15CC w U12 SL 
and U12 GA23/24CU w U6atac SL. The distal 3' SL (nts. 91-109) of U6atac 
GG14/15CC plasmid was substituted with SLIII (nts. 109-125) of U12 snRNA to 
give rise to the U6atac GG14/15CC w U12 SL construct. Similarly, the U12 
GA23/24CU w U6atac SL construct was made by replacing SLIII (nts. 109-125) of 
U12 GA23/24CU plasmid with distal 3′ SL (nts. 91-109) of U6atac snRNA. 5′ 
phosphorylated mutagenic oligonucleotides were used for site directed 
mutagenesis using the Change-IT mutagenesis kit (USB Corporation, Santa Clara, 
CA). The sequences of mutant snRNAs were confirmed by DNA sequencing. 
 
2.3      P120 minigene construct 
 
The construction of P120 minigene and the mutations introduced in the 
intron F are described previously by Kolossova I. and Padgett R. A. (1997). P120 
minigene contains four exons (Exon 5 - 8) and three introns (intron E, F and G). 
The intron F is a U12-dependent intron flanked by U2-dependent introns (Figure 
15). The information about the complete genomic sequence of P120 minigene is 
provided in the appendix. 
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Figure 15: Schematic representation of U12-dependent intron containing P120 minigene. 
The above sequence comprising four exons (E5-7) and three introns (Int E, F and G) of P120 gene 
was amplified and cloned in mammalian expression vector pCB6. Intron F is the U12 dependent 
intron and the red arrows represent the forward and reverse gene specific primers used for 
NESTED PCR. 
 
2.4     In vivo 5' splice site genetic suppression assay 
  The 5′ splice site, in vivo genetic suppression assays have been described 
previously (Shukla G.C. et al., 2002; Dietrich R.C. et al., 2009; Shukla G.C. and 
Padgett R.A., 2004). This assay uses a minigene derived from the nucleolar 
proliferating antigen gene P120 or NOL1. The P120 minigene plasmid contains 
four exons (5–8) and three introns (E, F and G). Introns E and G are U2-dependent 
introns whereas intron F is a U12-dependent intron. For the 5′ splice site 
suppression assay, the P120 minigene carrying a CC5/6GG mutation in the 5′ 
splice site of intron F was used. CHO cells were co-transfected with P120 
CC5/6GG plasmid, U11 GG6/7CC suppressor snRNA and either U6atac 
GG14/15CC suppressor snRNA or U6atac GG14/15CC w U12 SL snRNA. For this 
experiment, 0.5 μg of P120 plasmid and 5 μg of each of the snRNA expression 
plasmids were used for transient transfection as described previously (Hall S.L. & 
Padgett R. A., 1996; Sikand K. and Shukla G.C., 2011). Where one or more snRNA 
plasmids were omitted, a corresponding amount of pUC19 plasmid DNA was 
substituted. Transfections with empty vector and wild type (WT) P120 plasmid 
E5 E6 E7 E8
IntFIntE IntG
Fwd
RevP-120	minigene
U12	dependent	intron
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were carried out as controls in all experiments. Total RNA was isolated from cells 
48 h after transfection and further processed as described by Sikand K. and Shukla 
G.C. (2011). Briefly, 500 ng of DNased RNA was reverse transcribed and PCR  
amplified using the Thermostable rTth Reverse Transcriptase RNA PCR kit 
(Applied Biosystems) and the following primers: 
Forward primer: GGCCCGGGAAGCTGCTGCTGGGATC 
Reverse primer: CTTCTAAGAACTCCACCAGCTCAGA 
  One microliter of the cDNA was then subjected to nested PCR under the 
following conditions: 94°C for 3 min, 25 cycles of 94°C for 1 min and 60°C for 1 min  
followed by a final extension at 68°C for 5 min. A reverse transcriptase minus 
control was performed to monitor DNA template contamination. PCR products  
were resolved on 3% agarose gel and were visualized using Ethidium Bromide 
(EtBr). The gel was scanned on a Typhoon 9410 variable mode imager (GE  
Healthcare, Little Chalfont, UK). Using ImageJ software, the intensity of bands was 
quantified. For each lane, the band intensity of each product (unspliced, U12  
spliced, U12-cryptic spliced and U2 cryptic spliced) was expressed as the 
percentage of the total product.  
Sequence of nested PCR primers used in 5′ splice site genetic suppression 
assays. 
Forward primer: TTGTGCTGCCCCCTGCTGGGGAGATG 
Reverse primer: TGAGCCCCAAAATCACGCAGAATTCC 
 
 
 
44	
	 	
2.5      In vivo branch site genetic suppression assay  
  The branch site of the U12-dependent intron F if P120 minigene contains 
the UC84/85AG mutation, which abolishes in vivo U12-dependent splicing. The 
U12 snRNA with compensatory mutation as GA23/24CU was sufficient to restore 
the wild type U12-dependent in vivo splicing (Hall S.L. and Padgett R.A., 1996). 
Second site mutations were introduced in the U12 snRNA, where the stem loop III 
was replaced with distal 3' stem loop of U6atac (nucleotide 91-109). U12 
suppressor plasmid having GA23/24CU mutation and U12 GA23/24CU with 
U6atac stem loop were co-transfected with branch site P120 mutant into cultured 
CHO cells as described previously (Hall S.L. and Padgett R.A., 1996; Brock J.E. 
et al., 2008). For these experiments, 0.5 µg of P120 plasmid and 5 µg of each of 
second site mutation carrying U12 snRNA expression plasmids were added to 
CHO cells. Where one or more U12 snRNA plasmids were omitted, a 
corresponding amount of pUC19 plasmid DNA was substituted. Total RNA was 
isolated from cells 48 h after transfection and further processed as described by 
Sikand K. and Shukla G.C. (2011). Briefly, 500 ng of DNase-treated RNA was 
reverse transcribed and PCR amplified using the Thermostable rTth Reverse 
Transcriptase RNA PCR kit (Applied Biosystems) and the following primers: 
Forward primer: GGCCCGGGAAGCTGCTGCTGGGATC 
Reverse primer: CTTCTAAGAACTCCACCAGCTCAGA 
One microliter of cDNA was then subjected to nested PCR under the 
following conditions: 94°C for 3 min, 25 cycles of 94°C for 1 min and 60°C for 1 min 
followed by a final extension at 68°C for 5 min. A reverse transcriptase minus 
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control was performed in all experiments to monitor DNA template contamination 
The nested PCR products were analyzed by agarose gel electrophoresis. The 
DNA bands were visualized using EtBr and scanned on Typhoon Image Scanner 
(GE Healthcare). Intensity of bands was quantified using the ImageJ software. 
Sequence of the primers used for nested PCR in branch site genetic suppression 
assays. 
 
Sequence of nested PCR primers used in branch site genetic suppression assays. 
Forward primer: TTGTGCTGCCCCCTGCTGGGGAGATG 
Reverse primer: TCAGACAGAGGGAAGAGGTCCATGA 
 
2.6     In vivo genetic suppression assay using binary splice site substrate 
 This assay also uses the same minigene derived from the nucleolar 
proliferating antigen gene P120 or NOL1. For the binary splice site suppression 
assay, intron F of the P120 minigene contained both the 5′ splice site CC5/6GG 
and the branch site UC84/85AG mutations. In this assay, CHO cells were co-
transfected with P120 CC5/6GG + UC84/85AG plasmid, U11 GG6/7CC snRNA, 
U6atac GG14/15CC snRNA or U6atac GG14/15CC w U12 SL snRNA or each of 
U6atac GG14/15CC distal 3′ SL mutants or U6atac chimera snRNAs and U12 
GA23/24CU snRNA or U12 GA23/24CU w U6atac SL snRNA. For all experiments, 
0.5 μg of P120 plasmid and 5 μg of each of the snRNA expression plasmids were 
used for transient transfection as described previously. Where one or more snRNA 
plasmids were omitted, a corresponding amount of pUC19 plasmid DNA was 
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substituted. Transfections with empty vector and wild type (WT) P120 plasmid 
were carried out as controls in all experiments. Total RNA was isolated from cells 
48 h after transfection, reverse-transcribed and PCR-amplified as described earlier 
(Sikand K. and Shukla G.C., 2011). A total of 500 ng of DNase-treated RNA was 
reverse transcribed and PCR amplified using the Thermostable rTth Reverse 
Transcriptase RNA PCR kit (Applied Biosystems) and the following primers: 
Forward primer: GGCCCGGGAAGCTGCTGCTGGGATC 
Reverse primer: CTTCTAAGAACTCCACCAGCTCAGA   
One microliter of the cDNA was then subjected to nested PCR under the 
following conditions: 94°C for 3 min, 25 cycles of 94°C for 1 min and 60°C for 1 min 
followed by a final extension at 68°C for 5 min. A reverse transcriptase minus 
control was performed in all experiments to monitor DNA template contamination. 
PCR products were visualized by agarose gel electrophoresis using EtBr and 
scanned on a Typhoon 9410 variable mode imager (GE Healthcare, Little Chalfont, 
UK). The intensity of bands was quantified using ImageJ software. For each lane, 
the band intensity of each product (unspliced, U12 spliced, U12-cryptic spliced and 
U2 cryptic spliced) was expressed as the percentage of the total product. Each 
snRNA suppressor construct was transfected a minimum of three times in two 
stocks of cells. Independent transfections and analyses gave essentially similar 
results.  
 
Sequence of nested PCR primers used in 5′ splice site genetic suppression 
assays. 
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Forward primer: TTGTGCTGCCCCCTGCTGGGGAGATG 
Reverse primer: TGAGCCCCAAAATCACGCAGAATTCC 
 
2.7      IPTG based induction of GST-tagged C-terminal RNA Recognition Motif 
and protein purification using affinity based method 
  GST-p65-C-RRM construct was received as a gift from Dr. Luhrmann’s lab 
as a bacterial stock. The bacterial culture (E. coli, BL 21 cells) was streaked on the 
Luria-broth (LB) plates with ampicillin as a drug resistance. A mini culture from 
single colony was prepared by picking single colony in 5ml of LB media and 
ampicillin. The inoculated mini-culture was incubated in a shaker at 37 0C, 300 
RPM for 12-16 hours. Next day the 40ml of LB media was inoculated with 0.1% of 
bacterial culture and let it grow under same conditions for 2-3 hours with constant 
monitoring of the optical density (O.D.) using spectrophotometer (from Fisher 
Scientific) at 260nm. Once the O.D. was reached in the range from 0.4-0.6 the 
bacterial culture was induced using 0.5 mM IPTG. The induced culture was again 
kept for shaking for another 4-5 hours. The culture without the addition of IPTG 
was used as a negative control for our protein induction experiment. After 4-5 
hours of induction 3 ml of the culture was spun at 14, 000 RPM at room 
temperature for 30 seconds and rest of the volume was spun in a different culture 
tube under same spinning conditions. The bacterial cell pellet from 3 ml of induced 
and un-induced culture was lysed in 4X loading buffer. The cells re-suspended in 
the loading buffer were boiled for 10 mins and the lysed cells were spun at 10,000 
× g for 30 seconds. The supernatant thus obtained was loaded on SDS-PAGE gel  
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with 4-12% gradient. Once the induction was confirmed The cell pellet obtained 
from the bigger culture was lysed with Bacterial Protein Extraction Reagent (B- 
PER) and further processed for protein purification. Fusion protein was purified by 
using the B-Per® GST Spin Purification Kit (Thermo Scientific/Pierce, Waltham,  
MA) according to the manufacturer’s recommendation and the kit protocol. Briefly, 
the column(s) were equilibrated to working temperature and all purifications were  
performed at room temperature. Samples were prepared by mixing protein extract 
with Equilibration/Wash Buffer so that the total volume equals at least two resin- 
bed volumes. The bottom tab from the Pierce Glutathione Spin Column was 
removed by gently twisting. After snapping the bottom part of the column, it was  
assembled into a collection tube. The columns were centrifuged at 700 × g for 2 
minutes to remove storage buffer. The column was equilibrated with two resin-bed  
volumes of Equilibration/Wash Buffer. The buffer was allowed to enter the resin 
bed. Another round of column centrifugation was done at 700 × g for 2 minutes to  
remove buffer. The protein lysate prepared in B-PER reagent was added to the 
column and allowed it to enter the resin bed. For maximal binding, the sample was 
 incubated for 30-60 minutes at room temperature or 4 0C on a rocking platform. 
The column was centrifuged again at 700 × g for 2 minutes and the flow-through  
was collected in a new centrifuge tube. Resin washing was performed with two 
resin-bed volumes of Equilibration/Wash Buffer and centrifugation was done at 700  
× g for 2 minutes. The wash step was repeated twice and GST-tagged fusion 
protein bound to the resin was eluted by adding one resin-bed volume of Elution  
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Buffer and centrifugation was done at 700 × g for 2 minutes. This step was 
repeated twice, collecting each fraction in a separate tube. The eluted protein was  
analyzed by resolving the eluate SDS-PAGE and staining with commassie brilliant 
blue. 
 
2.8     5' end labeling of the RNA oligos and Electrophoretic Mobility Shift 
Assay 
  RNA oligonucleotides with the WT U12 SLIII (nts. 109-125) sequence, and 
the WT and mutant U6atac distal 3′ SL (nts. 91-109) sequences were obtained 
from IDT (Coralville, IA). The sequence of the oligonucleotides from 5' to 3' 
orientation is given below and the mutations introduced are highlighted in red. 
WT U12    5’ - CCC GCC UAC UUU GCG GG    - 3’ 
WT U6atac   5’ – UGC CAC CUA CUU CGU GGC A - 3’ 
U6atac U98G  5’ – UGC CAC CGA CUU CGU GGC A - 3’ 
U6atac A99C  5’ – UGC CAC CUC CUU CGU GGC A - 3’ 
U6atac C100G  5’ – UGC CAC CUA GUU CGU GGC A - 3’ 
U6atac Stem 1  5’ – UGC CAU CUA CUU CAU GGC A - 3’ 
U6atac Stem 2  5’ – UGC CAC CUA CUU CCA CCG U - 3’ 
U6atac Stem 3  5’ – ACG GUG CUA CUU CCA CCG U – 3’ 
U6atac Stem 4  5’ – UGC CAG CUA CUU CCU GGC A - 3’ 
U6atac Stem 5  5’ – ACG GUC CUA CUU CGA CCG U - 3’ 
50	
	 	
U6atac Stem 6  5’ – GUG GCA CUA CUU CGU GGC A - 3’ 
U6atac Comp loop 5’ – UGC CAC GAU GAA GGU GGC A - 3’ 
These oligonucleotides were labeled at their 5′ ends using ATP γ-32 P (MP 
Biomedicals, Cleveland, Ohio) and T4 polynucleotide kinase (from New England 
Bio-labs) with the recommended recipe 
RNA oligonucleotides Up to 50pmol 
10X T4PNK Reaction Buffer 5 µl 
ATP 50 pmol of [γ-32P] ATP 
T4 Polynucleotide kinase 2 µl (20 units) 
Nuclease free water up to 50 µl 
 
  The labelled reaction was then passed through the Quick Spin Columns 
pre-containing RNase free suspension of Sephadex G-25 in STE buffer (10 mM 
Tris-HCl, pH 7.5, 1 mM EDTA, 100 mM NaCl) for radiolabeled RNA purification 
purpose. 
2 µl of the radiolabeled RNA eluate was resuspended in 5 ml of scintillation 
fluid and was subjected to the scintillation counter at Cleveland Stated University 
(Instrumentation facility). Two hundred thousand counts of 32P-labeled 
oligonucleotides were incubated with or without GST-p65-C-RRM (0, 20, 40, 60 
nmoles). A 20 µl reaction was prepared in the binding buffer containing 10 mM 
HEPES (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1 mM DDT and 5% glycerol. After 40 
min of incubation at room temperature, the reaction was loaded on a 6% native 
polyacrylamide gel with 5% glycerol. The gel was run for 3.5 h at 150 Volts and 
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then exposed overnight to a storage phosphor screen. The exposed screen was 
read using a Typhoon 9410 variable mode imager (GE Healthcare, Little Chalfont, 
UK). The intensity of the bands was quantified using ImageJ software. 
 
2.9     In vivo RNA protein pull down assay 
Full length p65 (1603bp) open reading frame (ORF) was cloned in pcDNA 
3.1 (-) mammalian expression plasmid with FLAG and 6 × His tag upstream (N-
terminal) and downstream (C-terminal) of the ORF respectively. Two hundred 
thousand Hela cells/ well were seeded in 6-well plate. 2 µg of the expression 
plasmid was transfected in each well using Lipofectamine 2000 (Life Technologies) 
according to the manufacturer’s protocol. Cells were washed with ice cold 1X 
phosphate buffer saline (PBS) buffer prior to collection and resuspension in 200 µl 
ice cold lysis buffer [100 mM KCl, 5 mM MgCl2, 10 mM HEPES (pH 7.0), 0.5% NP-
40, 1 mM DDT, 100 units/ml RNase inhibitor] for overnight storage at -80 0C. 100 
µl of Agarose A/G beads were centrifuged at 2000 × g for 2 min. The beads were 
washed with 300 µl of ice cold NT-2 buffer [50 mM Tris-HCl (pH 7.4), 150 mM 
NaCl, 1 mM MgCl2, 0.05% IGEPAL (NP-40)] thrice. Finally, the beads were 
resuspended in 5 ml of NT-2 buffer along with 5 µg of anti-FLAG antibody in a 15 
ml conical tube. The resuspended beads were mixed end to end overnight at 4 0C. 
Beads with no antibody were used as a negative control for this experiment. After 
12-14 hours, the cells resuspended in lysis buffer were centrifuged at 15000 × g 
for 15 min at 4 0C. The supernatant was saved for downstream experiments and 
the pellet was discarded. Simultaneously, the beads were centrifuged at 2000 × g 
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for 2 min at 4 0C. The anti-FLAG antibody conjugated beads were washed with ice 
cold NT-2 buffer three times and resuspended in 800 µl of IP buffer (100 mM DDT, 
0.5 M EDTA, 200 units of RNase inhibitor, add ice cold NT-2 buffer to make the 
volume up to 850µl). The cell lysate was added to this mixture and incubated at 4    
0C for 4 h with end to end mixing. After this incubation, 100 µl of the resuspended 
beads were collected in a new tube for total RNA extraction. All samples were 
centrifuged at 2000 × g for 2 min at 4 0C. The beads were washed 5 times with ice 
cold NT-2 buffer. For the final wash, beads were transferred to a new tube and 
RNA was extracted using Trizol following the manufacturer’s protocol. Total RNA 
was obtained after digesting DNA with DNase I (Promega). RNA was then reverse 
transcribed using an Improm-II cDNA synthesis Kit (Promega). This step was 
achieved by mixing the random hexamer and the oligo dT primers 9:1. The reaction 
where reverse transcriptase was omitted served as a control for RT specificity. The 
cDNA thus obtained was subjected to PCR amplification using sets of gene 
specific primers for U12, U6atac and U5 snRNAs. The schematic of the immuno-
precipitation is represented in Figure 16. 
 
The primers used for the PCR are listed below. 
U12 forward primer sequence: GAGTAAGGAAAATAACGATTCGGGG 
U12 reverse primer sequence: CAGGCATCCCGCAAAGTAGGC 
 
U6atac forward primer sequence: GTATGAAAGGAGAGAAGGTTAGC 
U6atac reverse primer sequence: GGTTAGATGCCACGAAGTAG 
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U5 forward primer sequence: CTCTGGTTTCTCTTCAGATCGC  
U5 reverse primer sequence: GCCAAGGCAAGGCTCAAAAAATTG 
 
 
 
Figure 16: Schematic representation of immuno-precipitation of FLAG tagged protein. Anti-
FLAG antibodies were immobilized on agarose A/G beads. The beads conjugated with antibody 
were incubated with total protein lysate. After washing the unbound protein, the 
beads/antibody/protein complex was harvested for total RNA. DNA contamination free RNA was 
obtained by treating the RNA with DNase. Using reverse transcription primers, the cDNA thus 
obtained was further used to amplify U12 and U6atac with gene specific primers. 
 
 
 
 
RNA	extraction	using	Trizol
DNased the	RNA		
cDNA synthesis
PCR	amplification	using	U12	and	U6atac
specific	primers	
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2.10    Hybrid U6atac snRNA designing strategy 
 
  In order to test the evolutionary relatedness of the 3' ends of U6atac from 
phylogenetically distant species, the following hybrid U6atac sequences were 
designed with GG14/15CC background. The designed fragments were 
synthesized from the Bio-Basic, Amherst, New York. These sequences were 
designed with Not I and BamH I restriction sites at the 5' and the 3' end 
respectively. The sequences thus obtained were sub-cloned in the mammalian 
expression vector pcDNA 3.1(-). The clones were further confirmed via both the 
restriction digestion as well as sequencing method.  Using these hybrid U6atac 
snRNAs genetic suppression assay was performed by using binary splice site 
mutant intron as a substrate. This assay required the co-expression of 
U11GG6/7CC, U12GA23/24CU and U6atac hybrid with GG14/15CC background 
mutation along with the substrate. The designed U6atac hybrid sequences are 
given below from 5' to 3' orientation. 
 
 
U6atac Human 
 
GTGTTGTATGAAACCAGAGAAGGTTAGCACTCCCCTTGACAAGGATGGAAGAGGCCCTC
GGGCCTGACAACACGCATACGGTTAAGGCATTGCCACCTACTTCGTGGCATCTAACCAT
CGTTTTT 
 
U6atac Human/Arabidopsis 
 
GTGTTGTATGAAACCAGAGAAGGTTAGCACTCCCCTTGACAAGGATGGAAGGACCTTCG
GGTCTTTGAACACATCCGGTTAAGGCTCTCCACATTCGTGTGGATCTAAACCCAATTTT
TT 
 
U6atac Human/Phytophthora 
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GTGTTGTATGAAACCAGAGAAGGTTAGCACTCCCCTTGACAAGGATGGAAGTGCGCGTA
TGCGTATCCAACCACTGGATGGTTTAAGCTCTGTCCTCCTCCGTGAAGACATCTACCAG
TTTTTTT 
 
U6atac Human/Drosophillo 
 
GTGTTGTATGAAACCAGAGAAGGTTAGCACTCCCCTTGACAAGGATGGAAGCACATAAA
CGGTCGGCTAGGCACAGACAAAAGCCGTCCACAAATTTTTTT 
 
U6atac Human/Trichinella 
 
GTGTTGTATGAAACCAGAGAAGGTTAGCACTCCCCTTGACAAGGATGGAAGAGAATTGT
CAGACAAGCACAACAGCAAAGATCGCCTACCTTTGCTCCCCATTTTTT 
 
2.11      Design and Expression of U11/U12 di-snRNP complex specific protein 
constructs 
  The cDNA sequences of Open Reading Frame (ORF) of seven U11/U12 di-
snRNP specific proteins were obtained from the NCBI website. The NCBI or 
GeneBank Reference sequence information is provided in the table below. The 
codon optimization and the genes were synthesized from Gene-Art (Life 
Technologies Corporation, CA, US). These genes were designed with the with NotI 
and BamHI restriction sites at the 5' and 3' end respectively for the sub-cloning 
purposes in mammalian expression vector, pcDNA3.1(-). The cloned fragments 
were confirmed by both double digestion using the same restriction enzymes as 
well as by sequencing.  For the purpose of in vivo immuno-precipitation 
experiments these cDNAs were tagged with FLAG tag and 6 × His tag at the N-
terminal and C-terminal end respectively. The sequences for the following genes 
with the complete design strategy is given in the appendix I section. 
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Protein NCBI Ref. Sequence Gene Bank Ref. sequence 
U11/U12 20K NM_001003692.1 *** 
U11/U12 25K NM_024571.3 *** 
U11/U12 31K *** BK005200.1 
U11/U12 35K NM_180699.2 *** 
U11/U12 48K *** BK005199.1 
U11/U12 59K *** BK005196.1 
U11/U12 65K *** BK005195.1 
 
Table 1: U11/U12 di-snRNP specific proteins with their respective NCBI reference sequence 
number or Gene Bank reference sequence number.  
 
  
Hela cells were seeded in 100mm plates a day before transfections. At the 
confluency of 70-80 %, cells were transfected with the 5 micrograms of U11/U12 
specific protein expressing constructs (described in 2.10) using Lipofectamine 
2000 (Invitrogen, Carlsbad, CA). 48 hours post transfections the cells were 
collected in centrifuge tubes and were harvested for protein by re-suspending in 
100 ul of M-PER (Mammalian Protein Expression Reagent; Pierce) supplemented 
with protease inhibitor and kinase inhibitor cocktail.  The tubes were incubated at 
room temperature for 40 mins with end to end mixing. After quantifying the protein 
concentration using Bradford reagent. 10 micrograms of the total protein was 
loaded and resolved on NuPAGE 4–12 % Bis-Tris gels (120 volt for 2 hours at 
room temperature) and electro-transferred to nitrocellulose membranes (80 volts 
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for 1.5 hours at 4 0C). The following antibodies were used: mouse monoclonal anti-
FLAG antibody (1:1000, SIGMA) and horseradish peroxidase conjugated anti-
mouse secondary antibody (1:10,000, GE Healthcare, Piscataway, NJ). Bands 
were detected using the Western blotting detection reagent (ROCHE) and LI-COR. 
 
2.12   Designing, induction and purification of U11/U12 di-snRNP complex 
specific protein in bacterial cells 
The open reading frame sequences of the seven U11/U12 di-snRNP 
specific proteins were obtained from the sources mentioned above in 2.11. For 
bacterial expression, the codon optimization for all the sequences was done by Dr. 
Anton A. Komar and the genes were synthesized from the Gene-Art (Life 
Technologies Corporation, CA, US). These genes were designed with Nde-I and 
BamH-I restriction sites on their 5' and 3' ends respectively for subsequent sub-
cloning purposes in the bacterial expression pET3a vector. The cloned fragments 
were confirmed by both double digestion using the same restriction enzymes as 
wells by sequencing. For the purification purposes these fragments were tagged 
with FLAG tag and 6 His tag at the N-terminal and C-terminal end respectively. 
The sequences for the following genes with complete design strategy is given in 
the appendices section. 
  The pET3a vectors containing gene of interest were transformed in the BL-
21 gold cells (Bacterial strain). A single bacterial colony was used to inoculate the 
5ml miniculture using drug resistance. The culture was allowed to grow over night 
at 37 0C at 350 RPM. 0.1 % of the this miniculture was used to inoculate 40ml of 
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Luria broth media. The growth of the bacterial cells was monitored by using 
spectrophotometer at 600 nm. The plane LB media was used for blanking the 
machine. When the O.D. was reached in the range of 0.4-0.6 the bacterial culture 
was induced by using 0.5 mM IPTG. The induced culture was incubated for 4-5 
hours in the shaker under the same conditions mentioned above. The culture with 
no IPTG induction was used as the negative control. 
  After 4-5 hours of induction the bacterial cells were harvested by 
centrifuging the culture at 5000 RPM for 5 minutes at room temperature. The cell 
pellet thus obtained was resuspended in 8 ml of the Guanidinium Lysis Buffer, pH 
7.8 (6 M Guanidine HCl, 20 mM Sodium phosphate, pH7.8 and 500 mM Nacl). 
After proper resuspension the cells with the lysis buffer were kept on the rocker for 
5-10 mins in order to insure thorough lysis. The cell lysates were sonicated with 
three 5 seconds pulse at high intensity followed by the centrifugation at 3000 × g 
for 15 mins to remove the cell debris. The supernatant was transferred to the fresh 
tube. Before the purification step 50 ul of the supernatant was resolved in 
denaturing SDS-PAGE gels to confirm the induction. 
  Since all the fusion proteins are expressing the 6 × His tag at the N-terminal, 
we used the His-Bind resin (EMD Millipore, USA). Before using it the resin was 
resuspended gently by end to end mixing in a tube. 2ml of the resin was used in a 
10 ml Purification Column and allowed the resin to settle down completely by low 
speed centrifugation at 800 × g for 1 min. The supernatant was removed very 
carefully avoiding the loss of resin. His-bind resin was washed with 6ml of nuclease 
free water followed by above mentioned low speed centrifugation. The resin pellet 
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was washed twice with the denaturing binding buffer (8 M Urea, 20 mM sodium 
phosphate pH 7.8, 500 mM NaCl). After washing the resin pellet was resuspended 
in 7 ml of the bacterial cell lysate and was incubated for 2 hours with gentle 
agitation followed by low speed centrifugation. The pellet was subsequently 
washed twice with denaturing binding buffer and twice with the denaturing wash 
buffer (8 M Urea, 20 mM NaH2PO4 pH 6.0, 500 mM NaCl). Finally, the His bound 
fusion protein was eluted by re-suspending the pellet in 2 ml of denaturing elution 
buffer (8 M Urea, 20 mM NaH2PO4 pH 4.0, 500 mM NaCl). In order to ensure the 
purification, the eluate was resolved on the denaturing SDS-PAGE gel with 4-12 
% gradient. 
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Chapter III 
 
RESULTS 
 
 
3.1      Structural and sequence similar elements of U6atac and U12 snRNAs 
 
  U6atac snRNA interacts with the 5' splice site after the U11 snRNA 
interactions with the 5' splice site is destabilized and U11 is released during B* 
complex formation. Simultaneously, U12 snRNA interacts with the branch site of 
U12-dependent intron. Both the U12-type specific snRNAs play a pivotal role in 
the catalyzing the splicing. The secondary structure present at the 3' end of these 
two snRNAs exhibit structural and sequence similarity. The alignment of these 
elements (nucleotides 109-125 of U12 snRNA and nucleotides 91-109 of U6atac) 
from two different snRNAs shows identical   7 nucleotides base in the loop region 
of both the stem loops (Figure 17).   
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Figure 17. Structure and sequences of the human U12 and U6atac snRNAs. (a) Line diagram 
showing the secondary structure of human U12 snRNA based on the model of Benecke H. et al., 
2005. The sequence and base pairing interactions of the SLIII are shown. (SL:stem-loop) (b) 
Schematic of the secondary structure of human U6atac (black) and U4atac (grey) snRNAs based 
on the model of Padgett and Shukla19. The sequence and base pairing interactions of the distal 3' 
SL of U6atac snRNA are shown. (c) Sequence comparison of the SLIII of U12 snRNA and distal 3' 
SL of U6atac snRNA. Asterisks denote identical nucleotides. Loop nucleotides are highlighted in 
grey. 
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3.2     U12 snRNA with U6atac distal 3' Stem-loop activates U12-dependent 
intron splicing 
  To test if the U6atac distal 3′ SL (nts. 91-109, Figure 17b) can functionally 
replace the p65 binding SL (nts. 109-125, Figure 17a) in U12 snRNA, we used the 
U12 branch site mutation suppressor assay. This assay relies on the base pairing 
of the P120 branch site UC84/85AG mutant with U12 snRNA containing a 
compensatory GA23/24CU mutation (Figure 18a). We modified the suppressor 
U12 snRNA containing a first site GA23/24CU mutation by replacing its p65 
binding apical SLIII (nts. 109-125, Figure 17a) with U6atac distal 3′ SL (nts. 91-
109, Figure 17b) as a second site mutation. P120 UC84/85AG alone was inactive 
in WT U12-dependent splicing; instead, the intron was spliced using a cryptic 3′ 
U12-dependent branch site (Figure 18b and c, lane 3) (Hall S.L. and Padgett R.A., 
1996; Sikand K. and Shukla G.C., 2011). Co-transfection of P120 UC84/85AG and 
U12 GA23/24CU suppressed the downstream cryptic splicing and restored the 
splicing from the WT U12-dependent splice sites (Figure 18b and c, lane 4). U12 
GA23/24CU with complementary loop nucleotide (nts. 114-120, Figure 17a) 
sequence show a reduced spliced phenotype as compared to WT with very little 
splicing from the cryptic splice site (Figure 18b and c, lane 5). U12 GA23/24CU 
with deleted SL (nts. 109-125, Figure 17a) was largely inactive for WT splicing 
(Figure 18b and c, lane 6) (Sikand K and Shukla G.C., 2011). Similar activation of 
WT splicing was observed when U12 GA23/24CU suppressor snRNA containing 
the U6atac distal 3′ SL (U12 GA23/24CU w U6atac SL) was co-transfected with 
P120 UC84/85AG (Figure 18b and c; compare lane 7 with lanes 2 and 4). These 
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results demonstrate that the U6atac distal 3′ SL, when expressed in the context of 
the U12 snRNA, can functionally replace the U12 SL that is bound by p65 during 
U12-dependent splicing.  
 
 
Figure 18: Effect of replacing the SLIII in U12 snRNA with the U6atac distal 3' SL on in vivo 
splicing. (a) Features of the branch site suppression assay. Wild type (WT) base pairing between 
human U12 snRNA and the branch site of the U12-dependent intron of P120 pre-mRNA is shown. 
The boxed nucleotides were mutated to their complementary nucleotides as shown. GA nucleotides 
at positions 23/24 in U12 snRNA were mutated to CU and the corresponding nucleotides UC at 
positions 84/85 in the branch site were mutated to AG. U12 GA23/24CU mutations are required to 
fully suppress the effect of the branch site UC84/85AG mutation. (b) Splicing phenotypes of P120 
WT and the P120 UC84/85AG mutant coexpressed with the indicated U12 snRNA mutants. CHO 
cells were transfected with the indicated constructs and splicing phenotypes were assayed by RT–
PCR. Lane M: 100 bp ladder. U12 GA23/24CU w U6atac SL denotes the U12 GA23/24CU snRNA 
construct containing the U6atac distal 3' SL in place of U12 SLIII. The positions of bands 
corresponding to unspliced RNA, RNA spliced at the normal U12-dependent splice sites (U12 
spliced) and RNA spliced at the cryptic U12-dependent splice sites (U12 cryptic spliced) are 
indicated. The cryptic spliced product results from the activation of a U12-dependent cryptic splice 
site in the downstream exon. (c) Quantitative analysis of spliced/unspliced products. Numbers (x-
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axis) correspond to the respective lanes of the gel shown in “b”. Error bars represent ±SE of three 
experiments.      
 
 
3.3      U12 snRNA Stem-loop III can functionally replace distal 3' Stem-loop 
of U6atac snRNA 
Next, we wanted to test if the U12 snRNA p65 binding SL (nts.109-125) is 
compatible for U6atac snRNA function in vivo. For this, we modified the suppressor 
U6atac snRNA containing a first site GG14/15CC mutation by replacing its distal 
3′ SL (nts. 91-109, Figure 17b) with U12 SL (nts. 109-125, Figure 17a) as second 
site mutation. This U12 SL-containing U6atac mutant was transfected along with 
the P120 CC5/6GG and U11 GG6/7CC mutants (Figure 19). The P120 CC5/6GG 
mutant was defective for WT U12-dependent splicing. Instead, cryptic splice sites 
were activated and a smaller intron was spliced via the U2-dependent splicing 
pathway (Figure 19b and c, lane 3) (Hall S.L. and Padgett R.A., 1996). The 
transfection of the U11 suppressor alone did not suppress the splicing defect 
(Figure 19b and c, lane 4). However, the U6atac GG14/15CC suppressor alone 
suppressed the splice site defect and partially restored splicing at the WT splice 
sites (Figure 19b and c, lane 5), demonstrating that the assay is U6atac-
dependent. Coexpression of the U11 and U6atac suppressors activated the P120 
CC5/6GG U12-type splicing to nearly WT levels, as both snRNAs are required for 
enhanced splicing activity of the P120 mutant intron (Figure 19b and c, lane 6) 
(Incorvaia R. and Padgett R.A., 1998; Dietrich R.C. et al., 2001). When we 
cotransfected P120 CC5/6GG with U11 GG6/7CC and the U6atac GG14/15CC 
suppressor containing the U12 snRNA SL as a second site mutation (U6atac 
GG14/15CC w U12 SL), the U12-dependent splicing of the P120 5′ splice site 
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mutant was restored to almost WT levels (Figure 19b and c; compare lane 7 with 
lanes 2, 6). This demonstrates that the U12 snRNA SL can functionally replace the 
distal 3′ SL of U6atac during U12-dependent splicing when expressed in the 
context of the U6atac suppressor snRNA. 
 
 
 
Figure 19: Effect of swapping the distal 3' SL in U6atac snRNA with the U12 SLIII on in vivo 
splicing. (a) Diagram of the 5′ splice site (SS) in vivo genetic suppression assay. The base pairing 
interactions between the WT (wild type) U11 snRNA and WT P120 pre-mRNA 5′ SS, and between 
the WT U6atac snRNA and pre-mRNA 5′SS are shown. The mutations introduced in U11 snRNA, 
U6atac snRNA and the P120 pre-mRNA's 5′SS are also indicated. The boxed nucleotides (shown 
on the left) were mutated to their complementary nucleotides as shown in the box on the right. Both 
the U11 GG6/7CC and U6atac GG14/15CC mutations are required to fully suppress the effect of 
the 5′SS CC5/6GG mutation. (b) Splicing phenotypes of the P120 WT and P120 CC5/6GG mutant 
co-expressed with the indicated U11 and U6atac snRNA mutants. Total RNA was extracted from 
CHO cells transfected with the indicated constructs and the in vivo splicing pattern was analyzed 
by RT-PCR. Lane M: 100 bp ladder. U6atac GG14/15CC w U12 SL denotes the U6atac 
GG14/15CC snRNA construct containing the SLIII of U12 snRNA in place of the U6atac distal 3' 
SL. The positions of bands corresponding to unspliced RNA, RNA spliced at the normal U12-
dependent splice sites (U12 spliced) and RNA spliced at the cryptic U2-dependent splice sites (U2 
cryptic) are indicated. The cryptic spliced product is a result of activation of U2-dependent cryptic 
splice sites in the U12-dependent intron of the P120 minigene. (c) Quantitative analysis of 
spliced/unspliced bands. Numbers (x-axis) correspond to the respective lanes of the gel shown in 
“b”. Error bars represent ±SE of three experiments.    
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3.4 Both U6atac and U12 Stem-loop elements are functionally 
interchangeable during U12-dependent intron splicing as determined by 
an in vivo binary splice site suppression assay 
  To demonstrate that both U6atac and U12 SL elements are functional when 
swapped between the U6atac and U12 snRNAs, we developed a novel minor 
intron's splicing specific binary 5' splice site and branch site mutation suppression 
assay. In this assay, we combined previously characterized 5′ splice site CC5/6GG 
and branch site UC84/85AG mutations of the P120 intron (Figure 20a) (Hall S.L. 
and Padgett R.A., 1996; Kolossova I. and Padgett R.A., 1997 Sikand K. and 
Shukla G.C., 2011; Dietrich R.C. et al., 2001; Shukla G.C. and Padgett R.A., 2004). 
This binary splice site (P120 CC5/6GG + UC84/85AG) mutant was inactive in U12-
dependent splicing and did not lead to cryptic splicing events that were observed 
in our previous 5′ splice site and branch site mutation suppressor assays (Figure 
20b and c, lane 3). The splicing of the P120 binary splice site mutant was restored 
only in the presence of all three suppressors (U11 GG6/7CC + U6atac GG14/15CC 
+ U12 GA23/24CU) (Figure 20b and c, lane 6, also compare with lanes 4 and 5; 
also see Figures 21c and 27b, lanes 3-6), suggesting that viable RNA-RNA base 
pairing interactions among all molecules are essential for the restoration of 
splicing. When we transfected the U6atac GG14/15CC suppressor snRNA 
containing the U12 SL (Figure 20b and c, lane 7) or the U12 GA23/24CU 
suppressor snRNA containing the U6atac SL (lane 8), or when U12 and U6atac 
suppressor snRNAs containing their respective second site SL mutations were 
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both cotransfected at the same time (lane 9), U12-dependent splicing was 
observed and restored to almost WT levels (Figure 20b and c, compare lanes 7, 
8, 9 with lanes 2 and 6). In summary, the above data show that SLs of U12 and 
U6atac snRNAs that have similar loop sequences and stem lengths are functional 
in in vivo U12-dependent splicing in different structural contexts within the 
spliceosome.     
 
 
 
 
Figure 20: Combined effect of the exchange of SLs in both U6atac and U12 snRNAs on in 
vivo splicing. (a) Features of the binary splice site suppression assay. In this assay, both 5′ SS 
and branch site mutations shown in Fig. 2 and 3 were present in the P120 U12-dependent intron. 
The U12-dependent intron containing 5′ SS CC5/6GG and branch site UC84/85AG mutations is 
shown. The base pairing interactions between U11 GG6/7CC, U6atac GG14/15CC, U12 
GA23/24CU snRNAs and the mutant 5′ SS and branch site of P120 intron are also shown. Boxed 
nucleotides denote the mutated nucleotides as shown in Fig. 2 and 3. (b) Splicing phenotypes of 
P120 WT and the P120 CC5/6GG + UC84/85AG mutant coexpressed with the indicated 
suppressor snRNA constructs. CHO cells were transiently transfected with the indicated constructs 
and total RNA was extracted. The splicing pattern of the U12-dependent P120 intron was analyzed 
by RT-PCR using primers designed to bind flanking exons. Lane M: 100 bp ladder. The positions 
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of bands corresponding to unspliced RNA, RNA spliced at the normal U12-dependent splice sites 
(U12 spliced) and RNA spliced at the cryptic U2-dependent splice sites (U2 cryptic) are indicated. 
(c) Quantitative analysis of spliced/unspliced products. Numbers on the x-axis correspond to the 
respective lanes of the gel shown in “b”. Error bars represent ±SE of three experiments.  
 
3.5  Differential in vivo U12-dependent intron splicing activation by 
evolutionarily distant chimeric (hybrid) U6atac snRNAs 
  With respect to both U2- and U12-dependent snRNAs, it is clear that only 
the regions or domains that are functional “business ends” of the snRNAs are 
conserved among most species. However, in regions other than the “business 
ends” there are some less pronounced secondary structure similarities that are 
shared by the snRNAs among phylogenetically distant species including 
Arabidopsis, Phytophthora, Drosophila and Trichinella (Lopez D. et al., 2008). 
Figure 21a and b shows the alignment of U6atac sequences and M-fold predicted 
secondary structure of the 3′ ends of U6atac snRNAs from different species. 
Previously, we have shown the importance of the 3' end of human U6atac snRNA 
as a guide element for recruiting minor tri-snRNP to the U12-dependent 
spliceosome. We next investigated if the 3' ends of U6atac snRNAs from 
phylogenetically distant species could activate U12-dependent splicing in our 
binary splice site mutation suppressor assay. For this, we replaced the human 
U6atac snRNA 3′ stem-loop (nucleotides 50 to 125) with that from Arabidopsis, 
Phytophthora, Drosophila and Trichinella in a GG14/15CC background. All 
chimeric U6atac snRNAs were coexpressed with the U11 suppressor (GG6/7CC), 
U12 suppressor (GA23/24CU) and P120 binary splice site mutant (CC5/6GG + 
UC84/85AG) as a reporter plasmid. Figure 21c shows the splicing phenotypes 
obtained with our binary splice site mutation suppressor assay. The splicing of the 
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binary splice site mutant was restored to WT levels only in the presence of the 
three suppressor snRNAs (U11 GG6/7CC + U6atac GG14/15CC + U12 
GA23/24CU; Figure 21c and d lanes 7, compare with lanes 2). Human U6atac 
GG14/15CC containing the 3' end of Arabidopsis U6atac snRNA only weakly 
supported U12-dependent splicing (Figure 21c and d, lane 8, compare with lane 
7), whereas a moderate level of U12-dependent splicing was observed with the 3' 
end of U6atac snRNA from Phytophthora (Figure 21c and d, lane 9). On the other 
hand, the 3′ end of U6atac snRNA from Drosophila (lane 10) and Trichinella (lane 
11) failed to restore the splicing of the binary mutant P120 minigene. This in vivo 
experiment shows that the 3' ends of the U6atac snRNAs from distant species are 
not interchangeable for U12-dependent splicing. 
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Figure 21: Activity of chimeric U6atac snRNAs in in vivo U12-dependent splicing. (a) 
Comparative sequence analysis of U6atac snRNAs from the indicated species. ‘*’ denotes the 
conservation of a nucleotide in at least three species. Nucleotide sequences in green boxes 
represent stem I and stem II formed by RNA-RNA base pair interactions between U4atac:U6atac 
snRNAs. The region of U6atac snRNA denoted by a solid line below the consensus nucleotide 
sequences at the 5' end of U6atac snRNA is referred to as the “business end” of the molecule. (b) 
Predicted MFold secondary structures of the 3' end of U6atac snRNA from Homo sapiens, 
Arabidopsis thaliana, Phytophthora infestans, Drosophila melanogaster and Trichnella spiralis. (c) 
Splicing phenotypes of the binary splice site mutant (P120 CC5/6GG + UC84/85AG) coexpresssed 
with Human chimeric U6atac snRNA containing the 3' end of U6atac snRNA from the species 
shown in Panel a & b.  Transfections, RT-PCR, cDNA amplification and gel electrophoresis was 
performed as described in the legend to Fig. 4. (d) Quantitation of unspliced and spliced products 
using Image J software. Numbers (x-axis) correspond to the respective lanes of the gel shown in 
“c”. 
 
3.6     The U11/U12 di-snRNP specific p65 protein interacts with U6atac 
snRNA 
As shown by Benecke H. et al., 2005 and illustrated in Figure 17a, the 
human U12 snRNA (nucleotides 114-119; CUACUU), which form the loop region 
of SLIII, bind to the C-terminal RRM of the p65 protein. U6atac snRNA contains an 
identical sequence (nucleotides97-102; CUACUU) in the loop of its distal 3' SL 
(Figure 17a, b and c), suggesting that this U6atac SL has the potential to interact 
with the U11/U12 p65 protein. To test if U6atac interacts with the p65 protein, we 
performed Electrophoretic Mobility Shift Assays (EMSA) using GST-fused purified, 
full length p65 protein (data not shown), as well as GST/p65 fusion protein 
containing only the C-terminal RRM domain, and the WT U6atac distal 3′ SL (nts. 
91-109) or WT U12 SLIII (nts. 109-125). C-terminal RRM of p65 was induced by 
using 0.5 mM IPTG. After inducing for 4-5 hours the bacterial cells were lysed and 
GST fused p65 protein was purified by using GST affinity based purification 
columns. In order to confirm, a fraction of purification protein was resolved on a 
denaturing acrylaminde/bis-acrylaminde gel (4-12%) (Figure 22).   
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Figure 22: GST fused C-terminal RRM domain purification. Upper panel represents the 
schematic of both full length as well as truncated version (containing only the c-terminal RRM) of 
U11/U12 di-snRNP specific 65K protein. Lower panel shows the purified protein using GST spin 
columns. Elution A, B and C shows the induction and purification for three different clones. Different 
lanes under each sample shows the sequential elution.      
 
The purified protein thus obtained was incubated in increasing 
concentration (20, 40 and 60 nmoles) with 200,000 counts of 5' end radiolabeled 
U12 (nucleotides 109-125) and U6atac (nucleotides 91-109) stem-loop RNA 
oligos. After resolving the RNA-protein complex on native PAGE gel with 5% 
glycerol, the p65 C-terminal RRM domain was found to interacting with WT U6atac 
distal 3' stem loop in a dose dependent pattern (Figure 23b). Consistent with the 
previous studies (Benecke H. et al., 2005) the U12 Stem loop III also followed the 
same interaction pattern when incubated with C-terminal RRM of the p65 protein 
(Figure 23a). Lane 1 in both the panels a & b of Figure 23 shows only the free 
radiolabeled U12 stem loop III and U6atac distal 3' stem loop oligo nucleotides at 
the bottom as this lane was not incubated with any purified protein. Lanes 2-4 (both 
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a & b) show the dose dependent shift of labeled RNA oligos for both U12 as well 
as U6atac. Lane 5 (panel a) shows the competition when radiolabeled U12 stem 
loop III was incubated 5-fold of un-labelled U6atac distal 3' stem loop along with 
the purified protein. Lane 5 (panel b) competition when radiolabeled U6atac distal 
3' stem loop was incubated 5-fold of un-labelled U12 stem loop III along with the 
purified protein. This observation clearly suggests that this interesting RNA-protein 
interaction happening between U6atac and p65 may also occur in the minor 
spliceosome in vivo.  
 
 
 
Figure 23: The C-terminal RRM of p65 binds to the distal 3' SL of U6atac snRNA. (a) EMSA 
of U12 SLIII with GST-p65-C-RRM. The sequence of the WT U12 SLIII RNA oligonucleotide is 
shown. 32P-labeled oligonucleotide was incubated with increasing concentrations of GST-p65-C-
RRM (0, 20, 40, 60 nmoles). RNA–protein complexes were separated on a 6% native 
polyacrylamide gel. (b) EMSA of the U6atac distal 3' SL with GST-p65-C-RRM. The sequence of 
the WT U6atac distal 3' SL RNA oligonucleotide is shown. 32P-labeled oligonucleotide was 
incubated with increasing concentrations of GST-p65-C-RRM (0, 20, 40, 60 nmoles). RNA–protein 
complexes were separated on a native 6% polyacrylamide gel. On the right side are labeled the 
position of the RNA-protein complex band and unbound RNA at the bottom of the gel. The upper 
and lower parts of the gel represent different exposures. 
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As far as U12-dependent spliceosome specific proteins are concerned, a 
set of seven (65K, 59K, 48K, 35K, 31K, 25K and 20K) proteins were identified in 
U11/U12 di-snRNP 18S complex (Will C.L. et al., 2004; Will C.L. et al., 1999). Four 
proteins (i.e., 59K, 48K, 35K, and 25K), of this complex were found to be 
associated with U11 snRNA (Will C.L. et al., 2004; Will C. L. et al., 2001). 
Among above mentioned proteins, Benecke et al. (2005) have 
demonstrated that p65 of 18S U11/U12 di-snRNP complex interacts to the stem-
loop III of U12 snRNA. Structural and sequence similarities of the stem-loop III of 
U12 snRNA with distal 3' stem-loop of U6atac snRNA gives rise to the notion that 
p65 might also potentially interact with U6atac. To test if p65 also interacts with the 
distal 3' stem-loop of U6atac snRNA in vivo, we generated recombinant p65 protein 
with FLAG-tag at the N-terminal and 6 × His tag at the C-terminal end (the 
sequence and designing strategy is provided in the Appendix 2). Just in case, if 
p65 interactions with U6atac snRNA is dependent on other U11/U12 di-snRNP 
specific proteins, we designed the fusion proteins for all the seven proteins of 
U11/U12 di-snRNP complex [20K (170 aa), 25K (123 aa), 31K (217 aa), 35K (246 
aa), 48K (342aa), 59K (485 aa) and 65K (517aa)] (Will C.L. et al., 2004). Before 
performing the immuno-precipitation experiment, we first tested the expression of 
these recombinant proteins in HeLa cells. Full length recombinant expression 
plasmids were transiently transfected into HeLa cells. The expression of the FLAG 
tagged expressing protein was determined by western blot analysis using anti-
FLAG antibody as shown in Figure 24. Further, for our in vivo RNA-protein 
interactions experiments, we only overexpressed 65K recombinant protein 
75	
	 	
expressing both the N-terminal as well as the C-terminal RRM in Hela cells (Figure 
24, lane 7). 
  
Figure 24: Ectopic expression of U11/U12 di-snRNP specific proteins in mammalian cells. 
Open reading frames of seven U11/U12 di-snRNP specific proteins, with FLAG tag and 6 His tag 
at the N- and C-terminal respectively, were cloned in mammalian expression vector pcDNA 3.1 (-) 
using Not I and BamH I restriction sites. These vectors were transfected in Hela cells and the after 
transfer of proteins, the membrane was probed with anti-FLAG antibody. Lane 1 shows the protein 
marker (Bio-Rad) and the following lanes (lane 2-8) show the expression of seven different proteins 
in Hela cells.    
  
Protein pull-down experiments were performed using anti-FLAG antibody 
conjugated to agarose A/G beads. To test the specificity of immune-precipitation 
of FLAG- p65- 6 x His using agarose A/G beads conjugated with the anti-FLAG 
antibody, western blot analysis was performed. The agarose A/G beads 
conjugated with the anti-FLAG antibody showed a clear band of fusion protein 
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when probed with anti-FLAG antibody (Figure 25, lane 2). A similar size protein 
was detected in the total protein lysate in which p65 fusion protein was over 
expressed ectopically (Figure 25, lane 4). For the specificity purposes, the agarose 
A/G beads without any conjugation with anti-FLAG antibody served as negative 
control for the immune precipitation experiment (Figure 25, lane 3). 
 
 
 
 
Figure 25: Immuno-precipitation of FLAG tagged p65. Anti-FLAG antibody conjugated agarose 
A/G beads were incubated with total protein lysate of cells over-expressing FLAG-p65-6xHis 
protein. The protein conjugated beads were denatured, resolved and probed with anti-FLAG 
antibody. Lane 1 shows the protein marker. Lane 2 and 4 shows the FLAG-p65-6xHis protein after 
immune-precipitation and from the total cell protein lysate. Lane 3 shows the pull down where 
beads were not conjugated with anti-FLAG antibody.     
  
After washing the unbound protein with NT-2 buffer, total RNA was 
extracted from the bound fraction and reverse-transcribed followed by PCR 
amplification for U6atac, U12 and U5 snRNAs using gene specific primer sets. 
Interestingly, not only the positive control U12 snRNA (Figure 26a, lane 3) was 
pulled down together with p65, but also the U6atac snRNA was identified in the 
immunoprecipitation of p65 (Figure 26c, lane 3). However, we failed to identify U5 
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snRNA in the same pull down (Figure 26e, lane 3) indicating the specificity of p65 
protein interactions with the two important snRNAs involved in catalyzing the 
removal of U12-dependent intron. We also performed a similar experiment with the 
N-terminal half of the p65 protein, but no U12 or U6atac snRNA was pulled down 
together with p65, suggesting that only the C-terminal RRM binds to both snRNAs 
(data not shown).   
 
 
 Figure 26: p65 interacts with endogenous U6atac snRNA. RT-PCR amplicons of U12 snRNA 
(117 bp) (Figure 26a), U6atac snRNA (106 bp) (Figure 26c) and U5 snRNA (111 bp) (Figure 26e). 
Panels b and d show the structure and p65 binding domains (illustrated by gray circles) of the U12 
and U6atac snRNAs, respectively. FLAG-tagged full length recombinant p65 was transfected into 
Hela cells. 48 h post transfection, p65 protein was pulled down using anti-FLAG antibody 
conjugated with agarose A/G beads and snRNA was analyzed by RT-PCR (lane 3). Agarose beads 
without anti-FLAG antibody (lanes 1 and 2) and +/- reverse transcriptase (RT), or beads conjugated 
with antibody but -RT (lane 4) serve as negative controls. 
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3.7     Sequence and secondary structure requirement of U6atac distal 3′ 
Stem-loop for in vivo U12-dependent intron splicing 
  Earlier studies of interaction of the U12 snRNA with the C-terminal RRM of 
the p65 protein showed that the U12 loop region, as well as specific 
ribonucleotides in U12 SLIII, are required for p65 binding (Benecke H. et al., 2005). 
In light of the ability of p65 to bind the U6atac distal 3′ SL, we investigated, in detail, 
the requirement of the latter for in vivo U12-dependent splicing, including the 
requirement of nucleotides in the U6atac distal 3′ SL, whose equivalent nucleotides 
in U12 SLIII are important for p65 binding (Benecke H. et al., 2005). For this, we 
used the binary splice site mutation suppression assay described above. We 
created a series of U6atac second site mutants in the loop and the double-stranded 
helix region of the distal 3' SL and cotransfected them together with the U12 
suppressor (GA23/24CU), U11 suppressor (GG6/7CC) and P120 double splice 
site mutant (CC5/6GG + UC84/85AG) reporter plasmid. The predicted secondary 
structure of the U6atac distal 3′ SL, positions of mutations and splicing phenotypes 
are shown in Figure 27a, b and c. Splicing of the P120 binary splice site mutant 
was restored in the presence of all three suppressors (U11 GG6/7CC + U6atac 
GG14/15CC + U12 GA23/24CU; Figure 27b and c, lane 7). The loop mutants 
U98G, A99C and C100G supported in vivo splicing nearly to the positive control 
levels (Figure 27a – loops; Figure 27b and c, compare lane 7 positive control with 
lanes 8, 9 and 10). Interestingly, the identity of the corresponding nucleotides 
(U115, A116, C117) in SLIII of human U12 snRNA is crucial for binding the C-
terminal RRM of the p65 protein (p65-C-RRM) (Benecke H. et al., 2005). Stem 1 
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mutant, 96C-104G/96U-104A (Figure 27a) was functional in in vivo splicing (Figure 
27b and c, lane 11). Similarly, the stem 4 mutant 96C-104G/96G-104C (Figure 
27a) was also active in U12-dependent splicing (Figure 27b and c, lane 14); 
significantly the equivalent base pair (113C-121G) in human U12 SLIII was shown 
to be important for the interaction of p65-C-RRM (Benecke H. et al., 2005). In the 
stem 2 mutant, nts. 104-109 were mutated to their complementary sequence to 
disrupt the formation of the putative stem structure (Figure 27a). Similarly, in the 
stem 6 mutant, nts. 91-96 were mutated to disrupt the stem (Figure 27a), whereas 
in the stem 3 mutant the putative helix structure was restored, albeit in a 
complementary orientation (Figure 27a). The stem 2 and stem 6 mutants were 
largely inactive in U12-dependent splicing (Figure 27b and c, lane 12 and 16), and 
the restoration of the stem (stem 3 mutant) only partially restored U12-dependent 
splicing (Figure 27b and c, lane 13). Taken together, these results suggest that a 
U6atac 3' helix structure and its sequence are important for U12-dependent 
splicing.   
  Because the corresponding base pair (113C-121G) in the human U12 SLIII 
is important for p65 binding, we next investigated if the restoration of wild type base 
pairing to the stem 3 mutant only at positions 96 and 104 (i.e. stem 5 mutant) would 
be sufficient to restore splicing activity. Comparison of lanes 13 (stem 3 mutant) 
and 15 (stem 5 mutant) in Figure 27b and c show that splicing was similarly 
inhibited with both the mutants. Taken together, the splicing phenotypes obtained 
with the stem 1, 4 and 5 mutants demonstrate that the identity of nucleotides 
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forming the loop closing base pair in the U6atac distal 3′ SL is not important for in 
vivo U12-dependent splicing.  
 To further test the requirement of the U6atac distal 3′ SL in U12-dependent 
splicing, we completely deleted the SL (nucleotides 91-109; SL Del mutant, Figure 
27a) or mutated the loop nucleotides 97-103 to their complementary sequence 
[Comp Loop mutant, Figure 27a and described in our earlier study (Dietrich R.C. 
et al., 2009)]. Both the SL Del and Comp Loop mutants were active in U12-
dependent splicing (Figure 27b and c, lanes 17 and 18). These results are 
consistent with our previous study, in which the SL Del mutant and the Comp Loop 
mutant were active in U12-dependent splicing in two different U6atac suppressor 
snRNA backgrounds (i.e., U6atac GG14/15CC and a U6/U6atac hybrid 
background) (Dietrich R.C. et al., 2009).   Moreover, both the comp loop and SL 
Del second site mutants in U12 GA23/24CU branch-site background appears to 
have reduced or no splicing, respectively as compared to WT (Figure 18b and c, 
lanes 5 and 6 this study which is consistent with Sikand K. and Shukla G.C., 2011 
shown in the Figure 27 lanes 4 and 6). These observations indicate that the U6atac 
distal 3′ SL is dispensable for in vivo U12- dependent splicing. However, when the 
SL is present, the sequence and structure of its stem appears to be important for 
efficient and productive U12-dependent splicing.  
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Figure 27: Effect of mutations in the distal 3' SL of U6atac snRNA on in vivo U12-dependent 
splicing. (a) Sequence of the WT U6atac distal 3' SL and mutations made in the SL are illustrated. 
These mutations were made in the U6atac snRNA carrying the GG14/15CC first site mutation. (b) 
Splicing phenotypes of the P120 WT and the P120 CC5/6GG + UC84/85AG mutant coexpressed 
with the indicated suppressor snRNA constructs. CHO cells were transiently transfected with the 
indicated constructs and total RNA was extracted. The splicing pattern of the U12-dependent P120 
intron was analyzed by RT-PCR using primers designed to bind flanking exons. Lane M: 100 bp 
ladder, lane E: Empty vector; RT(-), without reverse transcriptase. The positions of bands 
corresponding to unspliced RNA, RNA spliced at the normal U12-dependent splice sites (U12 
spliced) and RNA spliced at the cryptic U2-dependent splice sites (U2 cryptic) are indicated. (c) 
Quantitative analysis of the U12 unspliced/spliced bands. Lanes (x-axis) correspond to the 
respective lanes of the gel shown in (b). Error bars represent ±SE of three experiments. 
 
 
3.8 Differential binding of p65 protein with U6atac distal 3′ Stem-loop 
mutants 
  Next, we determined the structure/sequence of the U6atac distal 3′ SL that 
is required for interaction with p65. To this end, we analyzed the interaction of the 
p65 protein with the U6atac SL mutants tested for in vivo splicing activity. We used 
synthetic 5′ end, 32P-labeled RNAs spanning nts. 91-109 of each U6atac SL mutant 
described in Figure 28a and performed EMSA with p65-C-RRM-GST fusion 
protein. As shown in Figure 28a and b, the binding of the U98G and A99C loop 
mutants to p65 was compromised (Figure 28a, lane 6 and 8, compare with lane 
3). p65 binding was completely abolished with the C100G mutant (Figure 28a, lane 
10), indicating a critical requirement of loop nucleotide C100 for binding. In 
contrast, all three equivalent loop mutations in the human U12 SLIII (U115G, 
A116C and C117G) abolished in vitro binding of p65 (Benecke H. et al., 2005). As 
all three loop mutants were fully active in U12-dependent splicing (Figure 28b and 
c, lanes 8-10), this indicates that p65 binding to the U6atac distal 3′ SL is not 
required for splicing. Stem 1 mutant that carried a 96C-104G to 96U-104A mutation 
and stem 4 mutant that carried 96C-104G to 96G-104C changes were able to bind 
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the p65 protein (Figure 28a and b, lane 12 and 18). These mutants were also active 
for in vivo splicing (Figure 28b and c, lanes 11 and 14). Similar mutations in the  
equivalent base pair in the U12 SL showed reduced binding to p65 (Benecke H. 
et al., 2005). The stem 2 and stem 6 mutants, which disrupt stem formation, were  
unable to bind p65 (Figure 28a and b, lane 14 and 22). The stem 3 and stem 5 
mutants that were designed to maintain the structure of the U6atac distal 3′ SL but  
change the sequence of the stem, showed a moderate reduction in p65 binding as 
compared to the WT (Figure 28a and b, lane 16 and 20), indicating that the helix  
sequence may be important for in vivo binding of p65 to U6atac. The U12 SLIII 
equivalent of the stem 3 mutant did not bind p65 c-terminal RRM domain (Benecke  
H. et al., 2005). The inability of a WT loop closing base pair (Stem 5) to completely 
restore p65 binding, plus the nearly wildtype binding of RNAs with mutated loop  
closing base pairs U-A (Stem 1) and G-C (Stem 4), suggests that the identity of 
loop closing base pair is not important for p65 interaction with the human U6atac  
distal 3′ SL. As expected, the Comp Loop mutant, in which all loop nucleotides of 
the U6atac distal 3′ SL were mutated to their complementary sequences, was not  
bound by p65 (Figure 28a and b, lane 24). Interestingly, this mutant was active in 
U12-dependent splicing in vivo (Figure 28b and c, lane 18) (Dietrich R.C. et al.,  
2009). Taken together, these data indicate that the SL structure, as well as the 
identity of loop nucleotides are important for the interaction of p65 with the distal  
SL of U6atac snRNA, but that this interaction is not essential for U12-dependent 
splicing.  
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Figure 28. Effect of U6atac distal 3' SL mutations on p65-C-RRM binding. (a) EMSA of WT 
and mutant U6atac distal 3' SL (nts. 91-109) oligonucleotides with GST-p65-C-RRM. The location 
of the respective mutations in the U6atac SL RNA oligonucleotides are illustrated in Fig. 8a. WT  
U6atac distal 3' SL 32P-labeled oligonucleotides were incubated with 0 (lane 1), 20, (lane 2) 40 
(lane 3) and 60 (lane 4) nmoles of GST-p65-C-RRM. 32P-labeled oligonucleotides were incubated  
with (+) or without (-) GST-p65-C-RRM (40 nmoles). RNA–protein complexes were resolved on a 
6% native polyacrylamide gel. Arrows on the right denotes the position of the RNA-protein complex  
band and free RNA. The upper and lower parts of the gel represent different exposures. (b) 
Quantitation of the RNA-protein complex formed with 40 nmoles of GST-p65-C-RRM in the gel 
shown in “a”. The RNA-protein complex for the WT corresponds to lane 3 in Figure 28a.  
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  For convenience purpose Table 2 summarizes the in vivo U12-dependent 
intron splicing results from section 3.7 (Figure 27) and in vitro RNA-protein 
interactions represented in section 3.9 (Figure 28). 
 
 
Table 2: Summarizing the effect of mutations introduced in distal 3' stem loop of U6atac 
snRNA on in vivo U12-dependent splicing and in vitro RNA-protein interactions. The +++ 
indicate the wild type or restoration of splicing to the wild type levels. The ++ indicate the weak 
level of restoration as compared to the wild type. The + represents very weak restoration of splicing 
phenotype. The check mark indicates the in vitro RNA-protein interactions whereas, the cross sign 
shows the defect in in vitro interactions.        
U6atac	3’	SL
In-vivo
Splicing	
Phenotype
In-vitro
p65	binding
+	+	+ ü
+	+	+ C100G
+	+	+ ü
- - - û
+	- - ü
U6atac	3’	SL
In-vivo
Splicing	
Phenotype
In-vitro
p65	binding
+	+	+ ü
+	- - ü
- - - û
+ +	-
+	+	+ û
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Chapter IV 
 
DISCUSSIONS 
 
 
   The efficient and precise removal of non-coding intervening introns, from 
the precursor mRNAs, is an essential step in eukaryotic gene expression. Almost 
all metazoans contain two different types of introns classified on the bases of their 
relative occurrence in the genome.  To date, approximately 800 introns have been 
annotated as U12-dependent introns (U12 DataBase), which comprise only less 
than 0.5 % of the total introns in human genome or any given genome. The 
recognition of the splice sites and the catalytic reactions that result in splicing take 
place within one of the most complex mega-dalton molecular machineries in the 
cell called the spliceosome (Wahl M.C. et al., 2009; Will C.L. and Luhrmann R., 
2006). As these U12-dependent introns differ in their splice site sequences from 
the U2-dependent introns, their processing requires similar but distinct 
spliceosomal machinery. Each spliceosome is comprised of four distinct snRNAs, 
one common snRNA and a large number of associated proteins that along with 
snRNAs form small nuclear ribonucleoprotein particles called snRNPs. In addition, 
large number of additional 
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non-snRNP proteins are also associated with the spliceosome. Proteomic studies 
of in vitro assembled spliceosomes have suggested the involvement of 150–300 
individual polypeptides approximately (Wahl M.C. et al., 2009; Jurica M.S. and 
Moore M.J., 2002). The U2- and U12-dependent spliceosomes differ mainly in their 
snRNAs and snRNPs. U12-type introns are spliced less efficiently than the U2-
dependent introns, and is believed add another layer of gene regulation by limiting 
the expression of the host genes.    
  Recent advancements in the functional assays identified mutations (30G>A, 
51G>A, 55G>A, and 111G>A) in the gene encoding U4atac snRNA and linked 
these mutations with severe developmental disorder, MOPD I. Since U4atac 
snRNA plays an essential role in catalyzing U12-dependent intron splicing, these 
mutations cause defective U12-dependent splicing. Experimental evidences have 
demonstrated defective endogenous U12-dependent intron splicing, whereas the 
U2-dependent intron splicing was found to be normal in MOPD I patient fibroblast 
cells, suggesting the role of U12-dependent splicing in the development and 
human disease. This clearly indicates the significance of U-12 dependent intron 
splicing in regulating multiple important cellular processes other than directly 
related to the expression and function of the host genes (He H. et al., 2011).  
 All the snRNAs involved in the catalysis of either U2- or U12-dependent 
introns form complex secondary structures. The role of snRNAs in splicing is 
defined by their inter- and intra-molecular RNA-RNA interactions (Turunen J.J. et 
al., 2013; Staley J.P. & Guthrie C., 1998). In addition, snRNP proteins facilitate the 
recognition of introns and the assembly of the catalytic scaffold of the spliceosome 
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(Will C.L. and Luhrmann R., 2011; Will C.L. and Luhrmann R., 2005; Yan C. et al., 
2015; Hang J. et al., 2015). Mass spectrometry analyses of the major snRNPs 
including various spliceosomal complexes generated a comprehensive list of U2-
dependent spliceosomal proteins (Hartmuth K. et al., 2002; Jurica M.S. et al., 
2002; Makarov E.M. et al., 2002, Rappsilber J. et al., 2002; Zhou Z. et al., 2002). 
However, due to the relatively low abundance of the U11, U12, and U4atac/U6atac 
snRNPs, the knowledge of the protein composition of the minor spliceosome is far 
from complete (Montzka K.A. and Steitz J.A., 1988).  
Several studies have suggested that many spliceosomal proteins are 
shared by both the splicing machineries. Further, immunoprecipitation studies 
demonstrate that most of the proteins specifically associated with the tri-snRNP 
complexes involved in both the U2- as well as U12-dependent spliceosome are 
common (Luo H.R. et al, 1999; Schneider C. et al., 2002), which was also 
supported by in vitro binding studies (Nottrott S. et al., 2002). These evidences 
strongly support the idea for a homologous origin (i.e., common ancestry) of both 
the spliceosomes (Burge C.B. et al., 1998). SR (Serene-Arginine) protein family 
are considered as the accessory proteins facilitating the splicing mechanism, in 
addition to the snRNPs. Thus the members of the SR protein family which are 
required for the splicing of both the type introns are also shared by both 
spliceosomes (Hastings M.L. and Krainer A.R., 2001).  
Characterization of human 18S U11/U12 and 12S U11 snRNPs revealed 
the set of associated proteins. A set of seven novel U11/U12 proteins were 
identified which were not associated with major spliceosomes. The subset of seven 
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novel proteins found associates with the 12S U11 monoparticle are considered to 
contribute in the recognition of U12-type 5′ splice site of the intron. This 
demonstrates that the proteins, specifically involved in the formation of pre-
spliceosome, are unique to the U12- dependent spliceosome only (Will C.L. et al., 
2004). 
  The most extensively studied and highly abundant snRNAs of the U2-
dependent spliceosome, namely, U1, U2, U4, U5 and U6, perform various tasks 
during splicing, including the recognition of authentic splice sites. Similarly, their 
counterparts in the U12-dependent spliceosome (U11, U12, U4atac, U5 and 
U6atac) also function in intron recognition, as well as the establishment of the 
catalytic core of the U12-dependent spliceosome. The assembly of both 
spliceosomes involves the formation of a similar dynamic RNA network. The minor 
class spliceosomal snRNAs present an interesting model to study evolutionarily 
conserved inter- and intramolecular RNA-RNA interactions important for splicing.  
  In the U12-dependent spliceosome, various intramolecular RNA-RNA 
interactions, although evolutionarily conserved, appear to be functionally 
dispensable for in vivo U12-dependent splicing.  U12 snRNA is predicted to form 
an intricate secondary structure containing several stem–loops (SL I, SL IIa, SLIIb 
and SL III) and single-stranded regions. By performing the robust genetic 
suppression assays, recent evidence has shown that the highly conserved SLIIb 
structure of human U12 snRNA is redundant for U12-dependent in vivo splicing 
(Sikand K. and Shukla G.C., 2011). Shukla G.C and Padgett R.A. (2001) have also 
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demonstrated the interchangeability of similar sequence and structural elements 
between the snRNAs involved in U2- and U12-dependent spliceosome.  
U6, U2 and U5 snRNAs form the active catalytic core of U2 dependent 
spliceosome. During the spliceosome assembly process, the U6 snRNA forms an 
intramolecular stem-loop (ISL). This ISL element is formed after the U4atac snRNA 
interactions with the U6 are destabilized and is released. This structure has been 
shown to be important for the in vivo U2 dependent intron splicing and is proposed 
to be present near the catalytic center of the spliceosome. U6atac snRNA of U12-
dependent spliceosome is the functional analog of U6 snRNA, contains a similar 
stem-loop whose structure but not sequence is conserved between humans and 
plants. It has been shown that the chimeric U6/U6atac snRNAs in which the ISL of 
U6atac was replaced either by the human U6 or budding yeast U6-ISL were 
functional to activate the in vivo U12 dependent intron splicing (Shukla G.C. and 
Padgett R.A., 2001).  
  These results further suggested that wild-type U4 snRNA might be able to 
interact productively with the chimeric U6/U6atac snRNA where the ISL of U6atac 
was replaced with that of U6 from either human or budding yeast. In order to show 
the functionality of U4 snRNA in the minor class mutant U4 snRNA was designed 
to base pair with a mutant U6atac snRNA and was tested for activating in vivo U12-
dependent intron splicing. Crosslinking assay also supported this genetic 
interaction happening in vitro. These results indicate that a U4/U6atac di-snRNP 
can base pair and precisely splice a U12-dependent intron (Shukla G.C. and 
Padgett R.A., 2003). 
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  It has been shown that both spliceosomal and self-splicing group II introns 
require the function of similar small, metal binding RNA stem-loop elements 
located in U6 or U6atac snRNAs of the spliceosome or domain 5 (D5) of group II 
introns. Further, in an interesting study Shukla G.C. and Padgett R.A., (2002) 
reported that two different D5 elements can functionally replace the U6atac snRNA 
intramolecular stem-loop structure in an in vivo splicing assay. These data strongly 
argue for the interchangeability of components and structures between the two 
spliceosomes, and more importantly, for the dispensable nature of many of the 
substructures of snRNAs, which are outside of the “business end” of the 
molecules.   
  In the work described here, we show that the human U12 snRNA 
(nucleotides 109-125) and U6atac (Nucleotides 91-109) snRNA specific stem 
loops are functionally interchangeable in U12-dependent in vivo splicing. Our data 
suggest that a) the U6atac distal 3′ stem loop (nts. 91-109) plays an ambiguous 
role in U12-dependent splicing; b) the U6atac distal 3′ stem loop can bind in vitro 
as well as in vivo to the C-terminal RRM domain of p65, a protein of the U11/U12 
di-snRNP complex; and c) the U6atac distal 3′ stem loop can functionally replace 
the U12 SLIII in the context of the U12 snRNA. In addition, we also show the 
practicality of the binary splice site mutation suppressor assay for the in vivo study 
of U12-dependent splicing.  
  We began with the simple observation that human U12 and U6atac snRNAs 
have similar sequence and structure of stem loops. Using three different genetic 
suppression assay of U12-dependent in vivo splicing including at the 5' splice site, 
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branch site and the binary splice site (where 5' splice site and the branch site were 
simultaneously mutated) we have demonstrated that SLIII (nts. 109-125) of U12 
snRNA and distal 3′ SL (nts. 91-109) of U6atac snRNA can functionally replace 
each other (Figure 18-20). These experiments demonstrate that the structural and 
sequence similarity of the two stem loops is sufficient to allow them to be 
interchangeable between U12 and U6atac snRNA. These results also support the 
preexisting evidences showing the flexibility of snRNA elements in U12-dependent 
spliceosome. 
  As mentioned earlier, the U12 snRNA is predicted to fold into an intricate 
secondary structure containing multiple stem loops and single stranded sequence 
for Sm binding proteins. Stem loop IIb is dispensable, stem loop III (terminal stem 
loop) of U12 snRNA is indispensable for in vivo U12-dependent intron splicing 
(Sikand K. and Shukla G.C., 2011).   The stem loop III of U12 snRNA also serves 
as a binding site for the p65 protein, one of the seven U11/12 di-snRNP specific 
complex proteins (Benecke H. et al., 2005). It has been shown that the p65 protein 
performs dual binding activity by interacting directly with U12 snRNA stem-loop III 
via its C-terminal RRM and the U11-associated p59 protein via its N-terminal half 
(Will C.L. and Luhrmann R., 1997; Benecke H. et al., 2005).  
  Clear evidence for an interaction between p65 and the U6atac snRNA was 
provided by in vitro EMSA experiments. Our data show that the distal 3′ SL of 
U6atac snRNA can bind to the C-terminal RRM of p65 protein both in vitro and in 
vivo (Figure 23 and 26). The structure of the distal 3′ SL and the identity of loop 
nucleotides appears to play an important role in the binding of p65 (Figure 28). 
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Comparison of our p65-U6atac distal 3′ SL interaction data with the previously 
reported p65-U12 SLIII interaction data suggests that the determinants for p65 
interaction appear to be similar. The loops of human U12 SLIII and U6atac distal 
3′ SL have an identical nucleotide sequence, except for the 3′ most loop nucleotide 
which is U in human U12 and C in U6atac (Figure 17). The identity of loop 
nucleotides U115, A116 and C117 is critical for U12 SLIII interaction with p65-C-
RRM (Benecke H. et al., 2005). However, our data show that of the three 
equivalent loop nucleotides U98, A99 and C100 in the U6atac distal 3′ SL, only the 
identity of C100 is crucial for p65 binding (Figure 28). The loop closing base pair 
in both the U6atac distal 3′ SL and U12 SLIII is identical: 96C-104G in U6atac and 
113C-121G in U12 (Figure 17). However, whereas the identity of the loop closing 
base pair is an important determinant for p65 binding to the U12 SLIII (Benecke H. 
et al., 2005), these nucleotides do not appear to be important for the p65-U6atac 
distal 3′ SL interaction (Figure 28, Stem 1, 4 and 5 mutants). Similarly, altering the 
stem sequence of the U6atac distal 3′ SL had only a moderate effect on p65 
binding (Figure 28, stem 3 and 5 mutants). The disruption of SL structure abolished 
p65 binding to both U12 (Benecke H. et al., 2005) and U6atac SLs (Figure 28, 
stem 2 and 6 mutants), showing the requirement of a SL structure for p65 binding. 
The basis for these differences is not clear and we cannot currently rule out that 
these differences could be attributed to altered sample handling or experimental 
conditions used in this report and that of Benecke H. et al (2005). As the U6atac 
stem is longer and thus more stable due to the presence of an additional base, it 
may play a more important role in p65 binding. Likewise, the minor difference in 
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the loop sequence between U12 SLIII and the U6atac distal 3′ SL could also 
potentially contribute to the observed differences, although the 3′ most loop 
nucleotide is also C (as opposed to U) in the U12 snRNA of some organisms 
(Benecke H. et al., 2005).  To investigate the role of p65-U6atac snRNA interaction 
in U12-dependent splicing, we tested the activity of U6atac distal 3′ SL mutants in 
a binary splice site suppression assay. The C100G and complementary sequence 
(Comp Loop) loop mutants of U6atac distal 3′ SL, which were unable to bind the 
p65 protein (Figure 28), exhibited nearly WT activity in U12-dependent in vivo 
splicing (Figure 27b and c), thus indicating that the p65-U6atac distal 3′ SL 
interaction is not important at least for in vivo U12-dependent splicing. The ability 
of p65 to bind the other U6atac distal 3′ SL mutants (Figure 28) correlated with the 
in vivo splicing activity of these mutants (Figure 27b). It is possible that disruption 
of the p65-U6atac interaction can be compensated by other structures in the U12-
dependent spliceosome, hence, resulting in little or no effect on splicing activity. 
The structural similarity between the U6atac distal 3′ SL and U12 SLIII, and the 
functional interchangeability between the SLs as demonstrated by domain 
swapping experiments, seem to support this possibility. 
  Published reports have shown that the RNA structures and interacting 
proteins serve to facilitate the formation of the functional RNA-protein scaffold 
necessary for biological reactions. Such RNA scaffolds appear to provide a 
dynamic option for multiple stoichiometric protein assemblies (Delebecque C.J. et 
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al., 2012). Nevertheless, in the absence of stable RNA-protein interactions, the key 
chemical reactions could still be carried out, although with compromised efficiency.  
  Recent findings show that many RNAs undergo various structural 
conformations through transitory dynamic stages to assist the formation of higher 
order RNP complexes to accomplish complicated processing events such as RNA 
splicing and translation. In the yeast telomere RNA scaffold, the telomerase RNP 
was still functional despite the presence of significant stiffening of its RNA 
component (Lebo K.J. and Zappulla D.C, 2012). Massive RNA scaffolds that are 
constructed by a large number of RNA structures of dispensable nature, perhaps 
provide an important evolutionary advantage to the chemical or enzymatic reaction 
to be accomplished by the whole complex, in this case, the spliceosome. The self-
catalytic group II introns occur in a variety of sizes and are conserved in 
evolutionarily divergent organisms (Candales M.A. et al., 2012). However, most of 
the intronic RNA is dispensable for at least in vitro splicing of the intron. Many 
reports have shown that mutations that are lethal for in vitro splicing appear to be 
functional in in vivo splicing (Lambowitz A.M. and Zimmerly S., 2004; Michel F. et 
al., 2009; Simon D.M. et al., 2009; Keating K.S. et al., 2010). The proposal that the 
snRNAs are evolutionary descendants of group II intron domains, is thus 
consistent with the dispensable nature of many substructures of snRNAs. These 
precedents are suggestive of structural and spatial support for many RNA 
secondary structures in the assembly and function of RNP machinery.  
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CHAPTER V 
 
CONCLUSIONS 
 
 
While a lot is known about the U2-dependent spliceosome, the structure-
function analysis of U12-dependent spliceosome is still under investigation. 
Intensive research has been conducted to explore the significant role of different 
secondary structures formed by the RNA-RNA base pair interactions outside the 
active catalytic core of the minor spliceosome. However, a lot of additional 
research studies related to the function of RNA-RNA and RNA-protein interactions 
in minor spliceosome is still on the way. There is a big gap in the understanding 
the role of numerous transient yet, important interactions and also the mechanism 
of how conserved but still dispensable elements contribute in regulating the U12-
dependent intron splicing. Here in this study, we have investigated the functional 
role of a substructure (distal 3' stem-loop) present in the 3' end of U6atac snRNA 
in mammals. The entire 3' end has two stem loops and a single stranded region 
and has been demonstrated to act as a guide element for the tri-snRNP complex 
specifically to the minor class intron.  
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Results obtained from the comprehensive studies that were conducted 
during this work are novel and demonstrate the functional significance of the distal 
3' stem loop of U6atac snRNA in U12-dependent spliceosome. Our studies 
conclude that a sub structure in the conserved 3' end of the U6atac snRNA has 
both structural as well as sequence similarity with the terminal element of stem 
loop III in U12 snRNA. Both U6atac and U12 snRNAs play a vital role in the 
catalysis of U12-depepdnent intron splicing. Alignment of these two elements 
shows a seven nucleotide base identity in the loop region and the conservation of 
these nucleotides in U12 snRNA signifies its importance in U6atac snRNA also. 
Domain swapping experiments conducted between U12 and U6atac clearly 
indicates that U6atac modified with terminal stem loop III of U12 snRNA and vice 
versa can efficiently activate the U12-dependent intron splicing.  
Further, in-vitro studies have revealed the p65 C-terminal RRM interactions 
with terminal U12 stem loop III, which is indispensable for in vivo U12-dependent 
splicing. All the above observation convinced to hypothesize that p65 can 
apparently interact with U6atac and our electrophoretic mobility shift assay 
supported our hypothesis. In vitro analysis with various mutations introduced in 
both the helix as well as the loop region of the distal stem loop of U6atac revealed 
that the determinants which affect the p65 interaction with U6atac are different 
from that of the U12 snRNAs. Briefly, the structure and sequence of the helix region 
is important for in vitro RNA-protein interactions. Immuno-precipitation assay with 
total cell lysate confirmed the in vivo p65 interactions with U6atac snRNA.   
In addition, using robust and stringent binary splice site genetic suppression 
98	
	 	
assay, which demonstrate various RNA-RNA base pair interactions in the 
spliceosome, we concluded that single nucleotide mutations introduced in the loop 
region of the distal 3' stem loop of U6atac snRNA does not affect the in vivo splicing 
activity of U12-dependent intron. Mutations that disrupted the RNA-RNA base pair 
interactions in the helix region of distal 3' stem loop resulted in defective in vivo 
splicing. Restoration of the interactions by complementing the helix sequence 
could restore the splicing back but not up to the wild type levels. These results also 
support the in vitro p65-U6atac interactions. To our surprise, the distal 3' stem loop 
mutant of U6atac was able to activate the in vivo U12-dependent splicing. This 
observation makes it hard to draw direct significance of p65 interactions with 
U6atac snRNA for U12-dependent in vivo splicing. Finally, we have shown that the 
3' ends of U6atac from phylogenetically distant species are functionally active for 
in vivo splicing.  
There are evidences which show that subtle mutations affect the in vivo 
splicing whereas, full deletion of the RNA element still continue to support the in 
vivo U12 dependent intron splicing (Dietrich R.C. et al., 2009; also consistent with 
our findings). However, the cause with detailed mechanism has not yet been 
discovered. Recent report from Younis I. et al. (2013) has demonstrated the 
supporting mechanism for the slower rate of U12-dependent intron splicing as 
compared to U2-dependent splicing. In addition to the lower copy number 
(approximately 2000/ cell), shorter half-life (t½<2 hr) indicates that U6atac is highly 
unstable as compared to the other U12-depenednt snRNAs which further suggest 
that level of U6atac indeed is a rate limiting factor U12-type intron splicing. 
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p38MAPK mediated modulation of the levels of U6atac snRNA reflected the 
corresponding change in the mRNA expression of the minor class intron containing 
host genes (Younis I. et al., 20013).  
Our work has potentially demonstrated the regulatory role of distal 3' stem-
loop of U6atac snRNA in U12-dependent intron splicing. The fact that the minor 
class intron splicing can happen in distal 3' stem-loop deleted mutant of U6atac 
snRNA, supports the notion that this RNA element might be involved in fine-tuning 
the U12-dependent intron splicing. Different mutations introduced in the distal 3' 
stem-loop of U6atac leading to differential splicing phenotypes could be possibly 
due to the variability in half-life of the snRNA. The inability of p65 protein 
interactions with those mutants where the stem-loop structure was completely 
disrupted (Stem 2 and 6, Figure 27) appears to regulate splicing by modulating the 
stability of U6atac snRNA (Figure 29). More experimental evidences are needed 
to demonstrate the role of p65 interactions in U12-dependent splicing. Based on 
our findings from these observations, exploring the effect of similar mutations on 
the stability of U6atac snRNA could be one of the potential future directions of this 
project.   
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Figure 29: U6atac distal 3' stem-loop mediated fine-tuning of U12-dependent intron splicing. 
U6atac snRNA levels limit the splicing of U12-dependent intron. The distal 3' stem-loop of U6atac 
appears to play an important role in fine-tuning the splicing events. Right branch depicts the intact 
stem-loop element hence resulting in the normal splicing phenotype. However, the stem-loop 
deletion mutant results in compromised splicing (left panel) indicating that stability difference could 
be the possible factor. Whether or not the interactions of p65 to the distal 3' stem-loop plays any 
significant role in modulating the stability is still not known.       
     
Mutations in snRNA that interfere with important RNA-protein interactions 
which ultimately lead to defective spliceosomal assembly and defective in vivo U12 
dependent splicing have been reported (He H. et al., 2011; Daniele M. et al., 2015). 
So dissecting the mechanism of how and at what step the spliceosomal assembly 
is compromised when p65 interactions with U6atac are impaired, could be 
explored in future.   
Based on the observation that 65K protein can interact with the other 
snRNA outside the U11/U12 di-snRNP complex, we want to perform a 
comprehensive, both in vivo as well as in vitro, RNA-protein interaction analyses 
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by different possible combinations of minor class snRNAs and the di-snRNP 
specific proteins. We have shown the expression of the full length fusion proteins 
in the mammalian cells (Figure 24). By performing immunoprecipitation assay 
followed by the RNA sequencing we want to test the genome wide RNA-protein 
interactions in the entire transcriptome. Since four out of seven proteins in the di-
snRNPs do not have RNA recognition motifs but are still a part of the complex, we 
want to explore the possibility of protein-protein-RNA interactions by studying the 
in vitro super-shifts by incubating combination of two proteins with single minor 
class snRNA. For these in vitro studies we have already optimized the protocol of 
IPTG based induction and the purification process of these proteins are in progress 
(Figure 30).     
Figure 30: IPTG based induction of U11/U12 di-snRNP proteins in bacterial cells. The 
bacterial cells transformed with the constructs containing the gene of interest were induced using 
0.5mM IPTG. The cells were lysed and the total cell lysates were resolved on the SDS-PAGE gels. 
In both the panels (Left and Right) the left most lane represents the protein marker. The lane 
number labeled from 1-7 (Black) shows the total protein profile from un-induced bacterial culture 
Un-induced Induced Un-induced Induced
1				2				3					4				1					2					3					4 5 6 7 5 6 7
Pr
ot
ei
n	
m
ar
ke
r
Pr
ot
ei
n	
m
ar
ke
r
Stacking	4%
Resolving	10	%
70	kDa
50	kDa
37	kDa
25	kDa
20	kDa
102	
	 	
and the lane 1-7 (Red) shows the induction profile. Lane 1 is 20K, lane 2 is 25K, lane 3 is 31K, lane 
4 is 35K, lane 5 is 48K, lane 6 is 59K and lane 7 is 65K in both the color coded lane numbers. 
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Appendix 1. P120 Minigene sequence 
 
 The fragment of 987 base-pair containing four exons (Exon 5-8) and three 
introns (Intron E, F and G) was used a minigene. The wild type and the mutant 
construct constructs which were designed as previously described in Kolossova I. 
and Padgett R. A. (1997). The intron F is a U12-dependent intron (highlighted in 
red), with AT-AC as terminal dinucleotides, flanked by U2-dependent introns. 
Following is the complete sequence of the minigene which was cloned in pCB6 
vector where the expression of this gene was driven by CMV promoter.  
    
GGTACCTTGCTGCCCATTGAAAGAGCTGCTCGGAAGCAGAAGGCCCGGGAAGCTGCTGC
TGGGTGAGTTTTGGAAGCTATTGGGATGGAGCATAGGAACCCACTGGGGTGGGGAAGCT
GTGAGGAAGGAGGAGGTATCTGTTTTGGTCTGTGAATCACTCTGTTCCTGGACCTGTTT
CTAGGATCCAGTGGAGTGAAGAGGAGACCGAGGACGAGGAGGAAGAGAAAGAAGTGACC
CCTGAGTCAGGCCCCCCAAAGGTGGAAGAGGCAGATGGGGGCCTGCAGATCAATGTGGA
TGAGGAACCATTTGTGCTGCCCCCTGCTGGGGAGATGGAGCAGGatatccttgcagggc
agagtgaagagttaggaggaaggtggttgggagagggatttccaggccttaggacatca
tgacacagttccttaacaggcccacATGCCCAGGCTCCAGACCTGCAACGAGTTCACAA
GCGGATCCAGGATATTGTGGGAATTCTGCGTGATTTTGGGGCTCAGCGGGAGGAAGGGC
GGTCTCGTTCTGAATACCTGAACCGGCTCAAGAAGGATCTGGCCATTTACTACTCCTAT
GGAGACTTCCTGCTTGGCAAGCTCATGGACCTCTTCCCTCTGTCTGAGGTACTGGATTG
CCAGAATGCCTCTTTTGCTTTTCTTTTCTCGCCTCCTTACGCTGTGTAAGGAAGATGTT
CGGCCCCCTTGCTCCCCTCTTCTGACTGAGCTCCTTAGCCAGCCTCACTTATTCCCTGC
TGTCTTGCCCCGCAGCTGGTGGAGTTCTTAGAAGCTAATGAGGTGCCTCGGCCCGTCAC
CCTCCGGACCAATACCTTGAAAACCCGACGCCGAGACCTAAGCTTGCATGCCTGCAGGT
CGACTCTAGAGGATCCCGGGTGGCATCCCTGTGACCCCTCCCCAGTCCTCTCCTGGCCT
TGGAAGTTGCCACTCCAGTGCCCACCAGCCTTGTCCTAATAAA 
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Appendix 2. Sequences and designing strategy of U11/U12 di-snRNP 
complex specific protein constructs for mammalian expression 
 
The following are the cDNA sequences of open reading frames of the 
U11/U12 di-snRNP complex specific proteins explained in Material and Methods 
section 2.11. The genes were designed and codon optimized according to their 
expression in the mammalian cells. For all the sequences, Not I and BamH I 
restriction sites at the 5' and 3' ends respectively, are highlighted in yellow. 
Sequences in the green and red are the start and stop codons. FLAG tag sequence 
at the N-terminal is represented by the cyan color and the 6 × His tag is in magenta 
color at the C-terminal end of the sequence.   
 
(Met- Flag-p65-6His: 1610 bp) 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGGCAGCTCCCGAGCAGCCGCTTGCG
ATATCAAGGGGATGCACGAGCTCCTCCTCGCTTTCCCCGCCTCGGGGCGACCGAACCCT
TCTGGTCAGGCACCTGCCGGCTGAGCTTACTGCTGAGGAGAAAGAGGACTTGCTGAAGT
ACTTCGGGGCTCAGTCTGTGCGGGTCCTGTCAGATAAGGGGCGACTGAAACATACAGCT
TTTGCCACATTCCCTAATGAAAAAGCAGCTATAAAGGCATTGACAAGACTCCATCAACT
GAAACTTTTAGGTCATACTTTAGTCGTTGAATTTGCAAAAGAGCAAGATCGAGTTCACT
CCCCATGTCCCACTTCAGGTTCTGAAAAAAAAAAAAGGTCTGATGACCCTGTCGAAGAT
GATAAAGAAAAAAAAGAACTTGGTTATTTAACAGTAGAAAATGGAATTGCACCAAACCA
TGGGCTGACTTTTCCTTTAAATTCATGCCTCAAGTATATGTACCCACCACCTTCCAGCA
CAATCCTAGCAAACATTGTAAATGCCTTGGCAAGCGTGCCTAAGTTCTATGTACAGGTC
CTTCATCTTATGAATAAAATGAATTTGCCCACACCTTTTGGACCAATTACTGCGCGACC
TCCCATGTATGAAGACTATATGCCATTGCATGCACCTCTTCCACCCACATCTCCTCAGC
CACCTGAGGAACCTCCTTTGCCAGACGAGGATGAGGAATTATCTAGTGAAGAATCAGAA
TATGAAAGCACTGATGATGAGGACCGACAGAGAATGAACAAATTAATGGAACTAGCAAA
TCTTCAGCCCAAAAGACCTAAAACAATAAAGCAGCGCCATGTGAGAAAAAAGAGAAAAA
TAAAGGATATGTTGAATACACCTTTGTGTCCTTCACACAGCAGTTTACATCCAGTGCTG
TTACCTTCAGATGTATTTGACCAACCACAACCTGTAGGTAACAAAAGAATTGAATTCCA
TATATCTACCGACATGCCAGCTGCATTTAAGAAAGATTTAGAAAAGGAACAAAATTGTG
AGGAAAAAAATCATGATTTACCTGCTACTGAAGTTGATGCATCCAATATAGGATTTGGA
AAAATCTTCCCCAAACCTAATTTGGACATCACAGAGGAGATTAAAGAAGACTCTGATGA
AATGCCTTCAGAATGTATTTCTAGAAGGGAATTGGAAAAGGGCAGAATTTCTAGAGAAG
AAATGGAAACACTTTCAGTTTTCAGAAGTTATGAACCGGGTGAACCAAACTGTAGAATT
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TATGTAAAGAATTTAGCTAAACATGTTCAAGAAAAGGACCTTAAATATATTTTTGGAAG
ATATGTTGACTTTTCATCAGAAACACAGCGGATCATGTTTGATATACGTTTGATGAAAG
AAGGTCGTATGAAAGGACAAGCTTTCATTGGACTTCCTAATGAAAAAGCAGCAGCAAAA
GCCTTAAAGGAAGCTAATGGATATGTGCTTTTTGGAAAACCCATGGTGGTTCAGTTTGC
TCGATCTGCTAGACCAAAACAAGATCCTAAGGAAGGAAAAAGAAAGTGTCACCATCATC
ATCACCACTAAGGATCC 
 
 
 
 
 
 
(Met- Flag-p59-6His: 1514bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGGCCCTGCCACCATTCTTCGGCCAG
GGTCGCCCAGGCCCACCGCCCCCGCAGCCGCCGCCTCCTGCTCCTTTCGGCTGTCCGCC
ACCGCCGCTGCCCTCCCCGGCTTTCCCGCCGCCTCTCCCCCAGCGGCCCGGCCCTTTTC
CGGGGGCCTCCGCCCCCTTCCTTCAGCCTCCGCTGGCTCTGCAGCCCCGAGCCTCCGCG
GAGGCCTCCCGCGGCGGAGGCGGCGCTGGCGCCTTCTACCCGGTGCCACCACCGCCGCT
GCCTCCTCCGCCGCCCCAGTGTCGGCCCTTCCCGGGGACCGACGCCGGCGAGCGGCCGC
GGCCACCGCCTCCCGGCCCGGGGCCGCCCTGGAGCCCGCGGTGGCCTGAGGCGCCGCCG
CCGCCGGCCGACGTGCTCGGGGATGCGGCCCTCCAACGCCTGCGCGACCGGCAGTGGCT
GGAGGCGGTGTTCGGGACCCCGCGGCGGGCAGGCTGTCCGGTGCCCCAGCGCACGCATG
CCGGGCCCAGCCTTGGCGAAGTGCGCGCGCGATTGCTCCGGGCTCTGCGCCTGGTGCGG
CGGCTGCGCGGCCTGAGCCAGGCCCTGCGCGAGGCCGAAGCCGACGGCGCGGCCTGGGT
CCTGCTGTACTCCCAGACCGCGCCGCTGCGCGCGGAACTGGCCGAGCGGCTACAGCCGT
TGACCCAGGCTGCCTATGTGGGCGAGGCGCGGAGGAGGCTGGAGAGGGTCCGGCGCCGC
CGGCTGCGGCTTCGCGAGAGGGCCCGGGAACGCGAGGCCGAGCGGGAGGCAGAGGCCGC
GCGGGCAGTGGAACGCGAGCAGGAGATTGACCGCTGGAGGGTGAAGTGTGTGCAGGAGG
TGGAGGAGAAGAAGCGGGAGCAGGAACTCAAAGCAGCCGCTGATGGCGTACTATCTGAA
GTGAGGAAAAAACAAGCAGATACCAAAAGAATGGTGGACATTCTACGGGCTTTGGAGAA
ATTGAGGAAACTGAGGAAAGAGGCTGCAGCGAGGAAAGGGGTCTGTCCTCCAGCCTCAG
CAGATGAGACTTTTACGCATCATCTTCAGCGACTGAGAAAACTCATTAAAAAGCGCTCT
GAACTGTATGAAGCTGAAGAGAGAGCCCTCAGAGTTATGCTAGAAGGAGAACAAGAGGA
AGAGAGGAAAAGAGAATTAGAAAAGAAACAAAGAAAAGAAAAAGAGAAAATTTTACTTC
AGAAACGTGAAATTGAGTCCAAGTTGTTTGGGGATCCAGATGAGTTCCCACTTGCTCAC
CTCTTGGAGCCTTTCCGACAGTATTATCTCCAAGCCGAGCACTCCCTGCCAGCGCTCAT
CCAGATCAGGCATGATTGGGATCAGTACCTGGTGCCATCCGATCATCCCAAAGGCAACT
TCGTTCCCCAAGGATGGGTCCTTCCCCCGCTCCCCAGCAACGACATCTGGGCAACTGCT
GTTAAGCTGCATCACCATCATCATCACCACTAGGGATCC 
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(Met- Flag-p48-6His: 1076bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGGAGGGCGAGCCTCCACCTGTGGAG
GAGCGGCGGCGGCTGCAGGAGGAGCTGAACGAGTTCGTGGAGAGCGGCTGCCGGACGTT
GGAGGAGGTGACCGCGTCCCTGGGCTGGGACCTAGATAGTCTGGATCCCGGGGAAGAGG
AGGCGGCGGAGGATGAAGTTGTGATATGTCCATACGATTCCAATCATCACATGCCTAAA
TCATCTTTGGCAAAGCACATGGCATCTTGTAGATTGAGGAAAATGGGCTATACCAAAGA
AGAAGAGGATGAAATGTATAATCCTGAGTTTTTCTATGAAAATGTGAAGATACCTTCGA
TTACTTTGAATAAGGACTCACAATTCCAGATAATTAAACAAGCTAGAACTGCAGTTGGG
AAAGACAGTGATTGTTATAATCAAAGAATTTATTCTTCATTGCCTGTTGAAGTTCCTTT
GAATCACAAACGGTTTGTTTGTGATCTAACTCAAGCTGATCGTCTTGCCCTCTATGATT
TCGTAGTTGAGGAGACAAAGAAAAAGCGCTCTGATTCTCAAATTATTGAAAATGACAGC
GATCTCTTTGTAGACTTGGCTGCCAAAATCAATCAAGACAATAGTCGAAAAAGTCCAAA
ATCCTACCTTGAAATCCTGGCAGAAGTACGAGATTATAAAAGAAGACGCCAGTCCTATA
GAGCCAAGAATGTTCACATAACCAAGAAATCATATACTGAGGTGATTCGAGATGTGATA
AATGTGCACATGGAAGAACTCAGCAATCATTGGCAAGAAGAGCAAGAGAAGGCAGAGGA
TGATGCCGAAAAGAATGAAGAAAGGCGATCAGCTTCAGTAGATTCACGGCAGTCTGGTG
GAAGCTATTTGGATGCTGAGTGTTCACGACATAGAAGGGATAGGAGTAGAAGCCCACAT
AAAAGAAAAAGAAACAAAGATAAGGATAAAAACTGTGAGTCGAGAAGAAGGAAAGAGAG
GGATGGGGAAAGACACCATAGTCATAAAAGAAGAAAGCAAAAAATACACCATCATCATC
ACCACTAAGGATCC 
 
 
 
(Met- Flag-p35-6His: 797bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGAACGATTGGATGCCCATCGCCAAG
GAGTATGATCCACTCAAAGCGGGCAGCATTGATGGCACCGATGAAGACCCACACGACCG
CGCGGTCTGGAGGGCAATGCTGGCACGATATGTCCCCAACAAAGGTGTCATAGGAGATC
CCCTCCTCACCCTGTTTGTGGCCAGACTAAACTTGCAGACCAAGGAGGACAAATTAAAG
GAAGTCTTTTCCCGCTATGGTGACATCCGGCGGCTTCGGCTGGTCAGGGACTTGGTCAC
AGGTTTTTCAAAGGGCTACGCCTTCATCGAATACAAGGAGGAGCGTGCCGTGATCAAAG
CTTACCGAGATGCTGATGGCCTGGTTATTGACCAGCATGAGATATTTGTGGACTACGAG
CTGGAAAGGACTCTCAAAGGGTGGATCCCTCGGCGACTTGGAGGCGGTCTTGGGGGAAA
AAAGGAGTCTGGGCAACTGAGATTTGGGGGACGGGACCGGCCTTTTCGAAAACCTATTA
ACTTGCCAGTTGTTAAAAACGACCTCTATAGAGAGGGAAAACGGGAAAGGCGGGAGCGA
TCTCGATCCCGAGAAAGACACTGGGACTCGAGGACAAGGGATCGAGACCATGACAGGGG
CCGGGAGAAGAGATGGCAAGAAAGAGAGCCGACCAGGGTGTGGCCCGACAATGACTGGG
AGAGAGAGAGGGACTTCAGAGATGACAGGATCAAGGGGAGGGAGAAGAAGGAAAGAGGC
AAGCACCATCATCATCACCACTAGGGATCC 
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(Met- Flag-p31-6His: 710bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGAGTGGTGGATTGGCTCCAAGTAAG
AGCACAGTGTATGTATCCAACTTGCCTTTTTCCCTGACAAACAATGACTTGTACCGGAT
ATTTTCCAAGTATGGCAAAGTTGTAAAGGTTACCATCATGAAAGATAAAGATACCAGGA
AGAGTAAAGGGGTTGCATTTATTTTATTTTTGGATAAAGACTCTGCACAAAACTGTACC
AGGGCAATAAACAACAAACAGTTATTTGGTAGAGTGATAAAAGCAAGCATTGCTATTGA
CAATGGAAGAGCAGCTGAGTTCATCCGAAGGCGAAACTACTTTGATAAATCTAAGTGTT
ATGAATGTGGGGAAAGTGGACACTTAAGTTATGCCTGTCCGAAAAATATGCTCGGAGAA
CGTGAGCCTCCAAAGAAGAAAGAAAAAAAGAAAAAAAAGAAAGCTCCTGAACCAGAAGA
AGAAATTGAGGAAGTAGAAGAAAGTGAAGATGAAGGGGAGGATCCTGCTCTTGACAGCC
TCAGTCAGGCCATAGCATTCCAGCAAGCCAAAATTGAAGAAGAACAAAAAAAATGGAAA
CCCAGTTCAGGAGTCCCCTCAACATCAGATGATTCAAGACGCCCAAGGATAAAGAAAAG
CACATATTTCAGTGATGAGGAAGAACTTAGTGATCACCATCATCATCACCACTAAGGAT
CC 
 
 
 
(Met- Flag-p25-6His: 455bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGGACGTGTTCCAGGAGGGTCTGGCT
ATGGTGGTGCAGGACCCGCTGCTCTGCGATCTGCCGATCCAGGTTACTCTGGAAGAAGT
CAACTCCCAAATAGCCCTAGAATACGGCCAGGCAATGACGGTCCGAGTGTGCAAGATGG
ATGGAGAAGTAATGCCCGTGGTTGTAGTGCAGAGTGCCACAGTCCTGGACCTGAAGAAG
GCCATCCAGAGATACGTGCAGCTCAAGCAGGAGCGTGAAGGGGGCATTCAGCACATCAG
CTGGTCCTACGTGTGGAGGACGTACCATCTGACCTCTGCAGGAGAGAAACTCACGGAAG
ACAGAAAGAAGCTCCGAGACTACGGCATCCGGAATCGAGACGAGGTTTCCTTCATCAAA
AAGCTGAGGCAAAAGCACCATCATCATCACCACTGAGGATCC 
 
 
(Met- Flag-p20-6His: 569bp) 
 
 
GCGGCCGCATGGACTATAAGGATGACGATGACAAGGGGAAGCGATACTTCTGTGACTAC
TGCGACCGCTCCTTCCAGGACAACCTCCACAACCGCAAGAAGCACCTGAACGGGCTGCA
GCACCTCAAGGCCAAGAAGGTCTGGTACGACATGTTCCGAGATGCAGCTGCCATCTTGC
TGGATGAGCAGAACAAGCGGCCCTGCAGGAAGTTTCTACTGACAGGCCAGTGCGACTTT
GGCTCCAACTGCAGATTTTCCCACATGTCAGAGCGAGACCTGCAGGAGCTGAGCATCCA
GGTGGAGGAGGAGAGGCGAGCCAGGGAGTGGCTACTAGATGCTCCTGAGCTCCCCGAGG
GCCATCTGGAGGACTGGCTGGAGAAGAGAGCCAAGCGGCTGAGCTCAGCCCCAAGTAGC
AGGGCTGAACCCATCAGAACCACTGTCTTCCAGTACCCCGTGGGCTGGCCACCAGTTCA
GGAGCTGCCTCCATCCCTGCGGGCACCCCCACCTGGGGGGTGGCCTCTGCAGCCCAGAG
TCCAGTGGGGCCACCATCATCATCACCACTGAGGATCC 
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Appendix 3. Sequences and designing strategy of U11/U12 di-snRNP 
complex specific protein constructs for bacterial expression 
 
 
Following are the cDNA sequences of open reading frames of the U11/U12 
di-snRNP complex specific proteins explained in Material and Methods section 
2.12. The genes were designed and codon optimized according to their expression 
in the bacterial (BL21) cells. The sequence highlighted in yellow are the flanking 
sequences at the 5' and 3' end. The green color sequence represents the Nde I 
and BamH I restriction sites at the 5' and 3' ends respectively. The FLAG tag and 
the the 6 × His tag are in cyan and magenta colors. The start codon and the stop 
codon are in green and red colors respectively. 
 
 
(Met- Flag-p65-Gly-6His: 1629 bp) 
 
 
ggaaatatacatATGGACTATAAGGATGACGATGACAAGGCTGCTCCGGAACAGCCCTT
GGCTATATCTAGGGGATGTACTAGCAGCAGCTCGTTGAGCCCCCCGCGGGGTGACAGAA
CCTTGCTGGTCAGGCATCTGCCCGCTGAATTGACTGCTGAAGAAAAGGAAGACTTGCTG
AAATACTTTGGAGCTCAGAGCGTTCGCGTCCTGTCTGACAAAGGAAGACTGAAGCACAC
AGCTTTCGCAACATTTCCGAACGAAAAGGCTGCTATAAAAGCTTTGACAAGATTACATC
AACTGAAGTTGCTCGGGCATACTCTCGTCGTAGAATTCGCTAAGGAACAAGACAGAGTA
CATAGCCCGTGTCCGACTTCTGGGAGCGAAAAGAAGAAGCGCAGCGACGACCCGGTCGA
AGACGACAAGGAAAAGAAGGAATTGGGGTACCTCACAGTAGAAAACGGAATAGCTCCGA
ACCATGGACTGACTTTCCCGCTCAACTCTTGTTTAAAATACATGTACCCGCCGCCGAGC
AGCACAATCCTAGCTAACATAGTAAACGCATTGGCTAGCGTTCCGAAATTTTACGTACA
GGTCTTGCACTTGATGAACAAAATGAACTTGCCGACACCGTTCGGACCGATAACTGCTA
GACCGCCGATGTACGAAGACTACATGCCGTTGCACGCTCCGTTGCCGCCGACAAGCCCG
CAGCCGCCGGAAGAACCGCCGTTGCCGGACGAAGACGAAGAACTCAGCTCTGAAGAATC
TGAATACGAAAGCACTGACGACGAAGACAGACAGCGCATGAACAAACTCATGGAACTAG
CTAACTTGCAGCCGAAACGCCCGAAAACAATAAAACAGCGGCATGTTCGCAAAAAACGC
AAAATAAAAGACATGTTGAACACACCGTTGTGTCCGTCTCATAGCTCTCTCCATCCGGT
TCTGCTCCCGTCTGACGTATTCGACCAACCGCAACCGGTAGGGAACAAACGCATAGAAT
TTCATATAAGCACCGACATGCCGGCTGCTTTCAAAAAGGACCTCGAAAAAGAACAAAAC
TGTGAAGAAAAGAACCATGACCTCCCGGCTACTGAAGTAGACGCTAGCAACATAGGATT
CGGAAAAATCTTCCCGAAACCGAACTTGGACATCACAGAAGAAATAAAGGAAGACAGCG
ACGAAATGCCGTCTGAATGTATCAGCCGCCGCGAATTGGAAAAAGGTCGCATCAGCCGC
GAAGAAATGGAAACATTGTCTGTATTTCGCTCTTACGAACCCGGGGAACCGAACTGTCG
125	
	 	
CATCTACGTAAAAAACCTCGCTAAACATGTACAAGAAAAAGACTTGAAATACATATTCG
GACGCTACGTAGACTTCTCTTCTGAAACACAGCGCATCATGTTCGACATACGATTGATG
AAGGAAGGGCGAATGAAAGGACAAGCTTTTATAGGATTGCCGAACGAAAAGGCTGCTGC
TAAGGCACTCAAAGAAGCTAACGGATACGTTTTGTTCGGAAAACCGATGGTTGTACAGT
TCGCTAGAAGCGCTCGCCCGAAACAAGACCCGAAAGAAGGAAAACGCAAATGTgggcac
catcatcatcaccacTAATGAcggatccggctgcaa        
             
 
 
(Met- Flag-p59-Gly-6His: 1533 bp) 
 
 
ggaaatatacatATGGACTATAAGGATGACGATGACAAGGCACTGCCGCCGTTCTTCGG
CCAGGGGCGGCCGGGTCCGCCCCCGCCCCAGCCCCCCCCGCCGGCTCCGTTTGGTTGTC
CCCCGCCCCCCCTGCCGAGCCCCGCTTTTCCCCCCCCGTTACCGCAGCGCCCGGGTCCG
TTCCCCGGAGCAAGCGCACCGTTCCTCCAGCCGCCCCTGGCTCTGCAGCCGAGAGCAAG
CGCTGAAGCAAGCCGGGGTGGAGGTGGTGCTGGCGCCTTCTACCCCGTTCCGCCGCCCC
CCCTGCCGCCGCCCCCCCCGCAGTGTCGCCCGTTTCCCGGAACCGACGCAGGTGAACGC
CCCCGCCCGCCCCCGCCGGGTCCCGGACCCCCGTGGAGCCCCCGCTGGCCGGAAGCTCC
CCCCCCCCCCGCAGACGTTTTAGGAGACGCTGCATTACAACGGCTGCGGGACCGCCAGT
GGCTGGAAGCTGTTTTCGGAACCCCCCGCCGCGCTGGTTGTCCCGTTCCGCAGCGGACT
CATGCAGGACCGAGCTTGGGTGAAGTTCGGGCTAGATTGTTACGGGCTCTGCGGCTGGT
TCGCCGCCTGCGGGGTCTGAGCCAGGCACTGCGGGAAGCAGAAGCAGACGGTGCTGCAT
GGGTCCTGCTGTACAGCCAGACCGCTCCCCTGCGGGCTGAACTGGCAGAACGCCTACAG
CCCTTGACCCAGGCTGCATACGTTGGCGAAGCTCGCCGCCGCCTGGAACGCGTCCGCCG
GCGGCGCCTGCGCTTGCGGGAACGCGCACGCGAACGGGAAGCAGAACGCGAAGCTGAAG
CAGCTCGCGCTGTTGAACGGGAACAGGAAATAGACCGGTGGCGCGTTAAATGTGTTCAG
GAAGTTGAAGAAAAGAAGCGGGAACAGGAATTAAAAGCTGCAGCTGACGGTGTACTAAG
CGAAGTTCGCAAAAAACAAGCTGACACCAAACGCATGGTTGACATACTACGCGCTTTGG
AAAAGTTGCGCAAGCTGCGCAAGGAAGCTGCTGCTCGCAAAGGAGTCTGTCCGCCGGCA
TCTGCTGACGAAACTTTTACTCATCATTTGCAGAGACTGCGCAAATTAATAAAGAAACG
GAGCGAACTGTACGAAGCTGAAGAACGCGCATTAAGAGTAATGCTAGAAGGAGAACAAG
AAGAAGAACGCAAACGCGAACTCGAAAAAAAGCAACGCAAGGAAAAGGAAAAGATACTC
TTGCAGAAGCGAGAAATAGAAAGCAAATTGTTCGGAGACCCGGACGAATTTCCGTTGGC
TCATTTATTGGAACCGTTTAGACAGTACTACTTACAAGCAGAACATAGCCTGCCGGCTT
TAATCCAGATCCGCCATGACTGGGACCAGTACCTGGTTCCGAGCGACCATCCGAAGGGT
AACTTTGTACCGCAAGGATGGGTCTTGCCGCCCTTACCGAGCAACGACATCTGGGCTAC
TGCTGTAAAACTGCATgggcaccatcatcatcaccacTAATGAcggatccggctgcaa 
          
 
(Met- Flag-p48-Gly-6His: 1095 bp) 
 
 
ggaaatatacatATGGACTATAAGGATGACGATGACAAGGAAGGTGAACCGCCGCCGGT
TGAAGAACGCCGCCGCCTGCAGGAAGAACTGAACGAATTCGTTGAAAGCGGTTGTCGCA
CTTTGGAAGAAGTTACCGCTAGCCTGGGTTGGGACCTAGACTCTCTGGACCCGGGAGAA
GAAGAAGCTGCTGAAGACGAAGTAGTTATATGTCCGTACGACAGCAACCATCACATGCC
126	
	 	
GAAATCTAGCTTGGCTAAACACATGGCTAGCTGTCGCTTGCGCAAAATGGGTTACACCA
AGGAAGAAGAAGACGAAATGTACAACCCGGAATTCTTTTACGAAAACGTTAAAATACCG
TCGATAACTTTGAACAAAGACTCTCAATTTCAGATAATAAAACAAGCTCGCACTGCTGT
AGGAAAAGACTCTGACTGTTACAACCAACGCATCTACAGCTCTTTGCCGGTAGAAGTAC
CGTTGAACCATAAACGCTTCGTATGTGACCTAACTCAAGCTGACCGATTGGCATTATAC
GACTTTGTAGTAGAAGAAACAAAAAAGAAACGGAGCGACAGCCAAATAATAGAAAACGA
CAGCGACTTATTCGTAGACTTGGCTGCAAAAATCAACCAAGACAACTCTAGAAAATCTC
CGAAAAGCTACTTGGAAATCCTGGCTGAAGTAAGAGACTACAAACGCCGCCGGCAGAGC
TACCGCGCAAAAAACGTACATATAACCAAAAAGTCTTACACTGAAGTTATAAGAGACGT
TATAAACGTTCACATGGAAGAATTAAGCAACCATTGGCAAGAAGAACAAGAAAAAGCTG
AAGACGACGCAGAAAAAAACGAAGAACGCAGATCTGCTTCTGTAGACTCTCGCCAGAGC
GGGGGAAGCTACTTGGACGCTGAATGTTCTAGACATCGCCGCGACCGCTCTCGCAGCCC
GCATAAACGCAAACGCAACAAAGACAAAGACAAAAACTGTGAATCGCGCCGCCGCAAGG
AACGCGACGGAGAACGCCATCATTCTCATAAGCGCCGCAAACAAAAGATAgggcaccat
catcatcaccacTAATGAcggatccggctgcaa  
 
 
(Met- Flag-p35-Gly-6His: 816 bp) 
 
 
ggaaatatacatATGGACTATAAGGATGACGATGACAAGAACGACTGGATGCCGATCGC
AAAAGAATACGACCCGTTAAAAGCTGGTAGCATAGACGGTACCGACGAAGACCCGCATG
ACCGGGCTGTCTGGCGCGCTATGCTGGCTAGATACGTCCCGAACAAAGGGGTCATAGGA
GACCCGTTATTAACCCTGTTCGTTGCAAGACTAAACTTGCAGACCAAAGAAGACAAGCT
CAAAGAAGTCTTCAGCCGGTACGGGGACATCCGCCGCTTGCGCCTGGTCCGCGACTTGG
TCACAGGGTTCTCTAAAGGTTACGCATTCATCGAATACAAAGAAGAACGAGCAGTTATC
AAAGCTTACAGAGACGCTGACGGTCTGGTAATAGACCAGCATGAAATATTCGTTGACTA
CGAACTGGAACGCACTTTAAAAGGATGGATTCCGCGCAGATTGGGAGGTGGGTTGGGAG
GAAAGAAAGAAAGCGGACAACTGCGCTTCGGAGGACGCGACCGCCCGTTCAGAAAACCG
ATAAACTTGCCGGTAGTAAAAAACGACTTATACCGCGAAGGAAAACGCGAACGCCGCGA
AAGAAGCAGAAGCAGAGAACGCCATTGGGACTCGCGCACACGCGACAGAGACCATGACA
GGGGTCGGGAAAAACGCTGGCAAGAACGCGAACCCACCCGCGTTTGGCCGGACAACGAC
TGGGAACGCGAACGCGACTTTCGCGACGACCGCATCAAAGGAAGGGAAAAAAAAGAAAG
AGGTAAAgggcaccatcatcatcaccacTAATGAcggatccggctgcaa   
       
 
(Met- Flag-p31-Gly-6His: 729 bp) 
 
 
ggaaatatacatATGGACTATAAGGATGACGATGACAAGTCTGGGGGATTGGCTCCGTC
TAAAAGCACAGTTTACGTAAGCAACTTGCCGTTCAGCCTGACAAACAACGACCTCTACC
GGATATTCAGCAAATACGGTAAAGTAGTAAAAGTAACCATCATGAAAGACAAAGACACC
CGCAAATCTAAAGGAGTAGCTTTCATACTCTTCCTCGACAAAGACAGCGCTCAAAACTG
TACCCGCGCTATAAACAACAAGCAGCTCTTCGGGCGCGTTATAAAAGCTAGCATAGCTA
TAGACAACGGACGCGCTGCTGAATTCATCAGACGCAGAAACTACTTCGACAAGAGCAAA
TGTTACGAATGTGGAGAATCTGGACATCTCTCTTACGCATGTCCCAAAAACATGTTAGG
AGAACGAGAACCGCCGAAAAAAAAGGAAAAGAAAAAGAAGAAAAAGGCTCCGGAACCGG
127	
	 	
AAGAAGAAATAGAAGAAGTAGAAGAATCTGAAGACGAAGGAGAAGACCCGGCTTTGGAC
AGCTTATCTCAGGCAATAGCTTTTCAGCAAGCAAAGATAGAAGAAGAACAAAAGAAGTG
GAAGCCGTCTTCTGGAGTCCCGTCTACATCTGACGACTCTCGCCGGCCGCGCATAAAAA
AGAGCACATACTTTTCTGACGAAGAAGAACTCTCTGACgggcaccatcatcatcaccac
TAATGAcggatccggctgcaa     
 
 
(Met- Flag-p25-Gly-6His: 474 bp) 
 
          
ggaaatatacatATGGACTATAAGGATGACGATGACAAGGACGTTTTCCAGGAAGGGCT
GGCTATGGTTGTTCAGGACCCCCTGTTATGTGACCTGCCCATCCAGGTAACTCTGGAAG
AAGTCAACAGCCAAATAGCACTAGAATACGGTCAGGCTATGACTGTCAGAGTTTGTAAA
ATGGACGGAGAAGTAATGCCGGTTGTAGTAGTTCAGTCTGCAACAGTCCTGGACCTGAA
AAAAGCAATCCAGCGCTACGTTCAGTTAAAACAGGAACGAGAAGGAGGTATACAGCATA
TCAGCTGGAGCTACGTTTGGCGCACTTACCACCTGACCAGCGCTGGAGAAAAGTTAACT
GAAGACCGCAAAAAATTAAGAGACTACGGTATCCGCAACAGAGACGAAGTAAGCTTCAT
CAAGAAACTGCGCCAAAAAgggcaccatcatcatcaccacTAATGAcggatccggctgc
aa     
 
 
(Met- Flag-p20-Gly-6His: 588 bp) 
 
          
ggaaatatacatATGGACTATAAGGATGACGATGACAAGGGAAAAAGATACTTCTGTGA
CTACTGTGACCGGAGCTTCCAGGACAACTTACATAACCGGAAAAAACATCTGAACGGAC
TGCAGCATTTAAAAGCAAAAAAAGTCTGGTACGACATGTTTAGAGACGCTGCTGCAATC
TTGCTGGACGAACAGAACAAACGCCCGTGTCGCAAATTCCTACTGACAGGTCAGTGTGA
CTTCGGTAGCAACTGTCGCTTCAGCCACATGTCTGAAAGAGACCTGCAGGAACTGAGCA
TCCAGGTTGAAGAAGAACGCAGAGCACGCGAATGGCTACTAGACGCTCCGGAATTACCG
GAAGGTCATCTGGAAGACTGGCTGGAAAAGAGAGCAAAACGCCTGAGCTCTGCACCGTC
TAGCAGGGCTGAACCGATCCGCACCACTGTCTTCCAGTACCCGGTTGGTTGGCCGCCGG
TACAGGAACTGCCGCCGAGCCTGCGCGCTCCGCCGCCGGGAGGATGGCCGCTGCAGCCG
AGAGTCCAGTGGGGTgggcaccatcatcatcaccacTAATGAcggatccggctgcaa 
               
 
 
 
 
 
 
 
 
 
 
 
 
